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  PreamBle
Having looked at the issues raised by genetic testing of minors, and the professional 
guidelines, attitudes and practice in respect of such testing, it is apparent that much 
hangs on the perceived benefits and harms. 
This part of the report is concerned with analysing the purported benefits and harms 
of carrier, pre-symptomatic and susceptibility testing for both childhood and adult-
onset conditions, and the available evidence on the subject. 
.  terminology: Benefits and harms
This section focuses on the purported benefits and harms of genetic testing of 
minors. We use the terms ‘benefits’ and ‘harms’ rather than other dualisms, such as 
‘advantages’ and ‘disadvantages’, for a number of reasons. First, ‘benefit’ easily accords 
with the bioethical principle of beneficence (the health professional’s duty to do or 
produce good);1 and, likewise, harm accords with the principle of non-maleficence, 
or primum	non	nocere (first do no harm).2 They are thus appropriate lenses through 
which to consider the effects of genetic testing. Secondly, our legislation permitting 
minors of or over the age of sixteen years to make their own medical decisions explicitly 
uses the term ‘benefit’ to describe the kinds of procedures minors may consent or 
refuse to consent to (s 36(1), Care of Children Act 2004). It is thus essential that the 
effects of genetic testing are considered in terms of benefits and harms so that they 
can be analysed against our legislative framework for minors’ decision-making. And, 
finally, benefits and harms appear to be the dominant construction through which to 
examine genetic testing of minors given that reference to benefits, and more usually 
harms, are rife in the medical genetics literature, and in the professional position 
statements and guidelines discussed earlier. 
‘Benefit’ has a wide meaning. It covers a broad spectrum of advantages that may 
accrue to humans, including medical, physical, psychosocial, emotional and spiritual 
benefits. 
We define a beneficial medical intervention (which may give rise to a ‘medical benefit’) 
as a procedure or treatment designed to cure a disorder; suppress the symptoms of 
a disorder; or ameliorate the symptoms of a disorder. Other types of interventions 
available in the health-care setting, such as counselling or helping blind patients learn 
how to read Braille or walk with a stick, are psychosocial benefits, aimed at helping a 
patient cope or adjust to a disorder, and not strictly ‘medical benefits.’ 
There is great debate as to whether genetic testing of minors is beneficial or harmful, 
largely because of the limited empirical evidence on the effects of predictive testing 
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in minors in particular. Most of the major professional guidelines and position 
statements on genetic testing of minors take a cautionary stance, advocating 
abstention from the testing of minors generally (except where a medical benefit may 
accrue), in accordance with the perceived best interests of the minor.3 But is genetic 
testing of minors as harmful as is claimed? 
There is scant evidence of either psychosocial benefits or harms resulting from 
predictive testing of children. Thus, while there is little evidence that ‘pre-emptive 
knowledge of future ill-health’4 is a good, there is also limited evidence of the alleged 
harms it causes. There is more evidence relating to the effects of carrier testing in 
children, as these tests have been possible for much longer. 
.2  going beyond the huntington disease (hD) paradigm
Many of the earlier guidelines and commentaries on predictive genetic testing 
generally, and genetic testing of minors specifically, used testing for the Huntington 
disease (HD) mutation as an example or case study of potential benefits and harms.5 
However, the HD mutation is unusual among late-onset disorders in respect of its 




Hogben and Boddington challenge the frequent use of HD as the exemplar of a late-
onset disorder. They note that choosing HD as the standard in predictive testing 
discourse ‘inevitably acts to construct the information generated by predictive testing 
(in general) as highly undesirable’.7 Their special interest is the distinction drawn 
between carrier testing and predictive testing, and they criticise the role of the HD 
example in underestimating the effects of carrier testing ‘as “less serious” through 
implied contrast’.8 
This is one of the reasons why we consider and differentiate between the purported 
benefits and harms raised by the various kinds of genetic tests. Each condition for 
which testing is available, whether early or late-onset, or involving symptomatic, pre-
symptomatic, susceptibility or carrier testing, has different features to some extent 
and thus the implications of testing will differ accordingly. 
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.  minors who cannot give informed consent and competent minors
We deal separately with the benefits and harms arising from genetic testing of minors 
who request testing for themselves from the benefits and harms that may arise for 
those minors tested as a result of parental requests and consent. Different legal 
issues are raised for minors who seek testing themselves and those who are tested 
on the basis of parental consent – which is why the legal frameworks for medical 
decision-making in respect of each group of minors are also discussed separately in 
the following sections.
Additionally, one of the most frequently cited potential harms of genetic testing in 
childhood is that it infringes a minor’s autonomy to make a decision about testing. 
Opponents of genetic testing of minors argue that predictive and carrier testing of 
minors infringes their autonomy and the right not to be tested and not to know 
their genetic risk status as adults. Thus, many of the arguments against predictive or 
carrier testing of minors disappear or, at the very least, are mitigated in the context of 
competent minors seeking testing for themselves. 
Very little evidence is available of the actual benefits and harms that arise from genetic 
testing of minors. We discuss the benefits and harms of genetic testing of competent 
minors first largely because more evidence exists, thanks to Duncan’s research,9 of 
the outcomes of testing this group (compared to outcomes for those too young to 
give informed consent).
As Duncan states: 
Of	 the	 five	 empirical	 studies	 that	 have	 been	 conducted	 in	 order	 to	 answer	

















There is some evidence that minors occasionally request genetic testing.12 Some seek it 
on their own behalf, while others do so in conjunction with their parents or guardians. 
However, there is considerable disagreement as to whether minors should be tested at 
all, regardless of their competence. The issue therefore is the harmfulness of genetic 
testing. This section will consider the potential benefits and harms of genetic testing 
of competent minors to determine the validity of the perception of harm. 
Arguments opposing genetic testing in competent minors are generally premised on 
one or both of the following lines: the consequences of genetic testing may be too 
harmful to allow minors the ability to give legally effective consent to testing (even if 
they are competent to consent to other medical procedures); and genetic information 
and the implications of genetic testing are such that minors cannot competently 
comprehend them and give effective consent to testing. According to this view genetic 
testing could not be undertaken until the minor attained the age of eighteen.13 In this 
section we consider whether there is merit in the view that minors should not be 
granted access to genetic testing, even upon a competent request, by examining the 
harms and benefits of genetic testing. The limited evidence available regarding harms 
does not support the view that the consequences of testing would be too harmful for 
competent minors who request testing. The evidence there is suggests that not only 
are there benefits in testing competent minors, but also harm may result from not 
testing competent minors who for good reason request a genetic test. 
2.2  Benefits and harms for competent minors specifically
Much of the discourse and professional guidance on genetic testing and minors 
relates to minors too young to seek or give valid consent to genetic testing. Thus 
most of the debate focuses on parental rights with regard to their children’s medical 
treatment, the minor’s future autonomy and the best interests of the minor, including 
concerns about the potential misuse (whether intentional or otherwise) of genetic 
information. Many of the arguments against predictive testing of minors disappear 
or, at the very least, are mitigated in the context of competent minors who themselves 
are seeking testing. 
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Opponents of genetic testing of minors argue that predictive and carrier testing of 
minors infringes their autonomy and their right to not be tested and not to know 
their genetic risk status as an adult. Protecting a minor’s ‘future autonomy’ to make 
a decision about whether or not to undergo genetic testing is also connected to 
protection of confidentiality. A minor who undergoes a genetic test in response to 
a parental request will generally not be granted the same confidentiality as an adult, 
given that the results will be disclosed to parents. These are among the most forceful 
arguments against predictive testing of minors, and are discussed in greater detail 
later.
Arguments opposing testing in competent minors are somewhat self-defeating to 
the extent that they rely on protecting a minor’s autonomy and ‘future autonomy’. 
Denying an autonomous competent minor’s request for a genetic test in order to 





Additionally, where a minor is deemed competent to make a decision about 
genetic testing, the minor will also be entitled to confidentiality, as an autonomous 
individual. 
The benefit or harm of a genetic test is likely to be primarily subjective: does the 
competent minor who is seeking a genetic test consider that the test will be beneficial? 
The following factors, among others, may be relevant to the minor: the kind of genetic 
test in question; the kind of disorder being tested for; and the reasons why the test is 
being sought. For these reasons the analysis of benefits and harms is divided under 
headings relating to the different kinds of genetic tests available (as outlined in Tables 
1 and 2). 
The focus is on the potential benefits and harms of genetic testing for minors who are 
competent and who request testing for themselves. 




differences	 will	 result	 in	 a	 greater	 potential	 for	 harm	 or	 greater	 potential	 for	
benefit	when	young	people	undergo	such	testing.15
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2.3.1  Symptomatic testing
Symptomatic genetic testing for a disorder for which there is treatment available 
is generally considered to be beneficial: once the diagnosis is established, the 
appropriate treatment programme can begin. What about symptomatic genetic 
testing for a disorder for which there are no beneficial medical interventions available? 
Symptomatic testing is generally regarded as beneficial regardless of whether or not 
the disorder tested for can be medically managed. Benefits include: the cessation of 
appointments, procedures and tests (some of which might be invasive or harmful) 
in order to ascertain what is causing the symptoms; and the reassurance of knowing 
what is wrong and what to expect in terms of progression of the disorder, and 
therapeutic or other support. 
In cases such as these, where a specific genetic mutation is suspected, the health 
professional involved would almost certainly urge genetic testing because of the 
belief that the benefits of identifying the etiology (cause or origin) of the symptoms 
far outweigh any harms that might arise from having a clear diagnosis.16





The purpose and principle of symptomatic genetic testing is routine: the health 
professional is searching for the cause of symptoms (specifically seeking to establish 
whether they might have a genetic basis), as they would for any type of disorder 
via other methods of clinical examination or testing. The ethical implications of 
diagnosing certain conditions or attaching a potentially stigmatising diagnostic 
label to a child could arise equally in diagnosis of a child with HIV/Aids or other 
conditions. Other methods of symptomatic examination or testing can also have 
implications for family members, e.g. any form of examination or testing which 
indicates a heritable genetic mutation, or testing for any communicable virus such as 
HIV/Aids or hepatitis.
2.3.2  Predictive testing for late-onset disorders18
2.3.2.1  Pre-symptomatic testing for late-onset disorder for which there are beneficial   
 medical interventions
If pre-symptomatic surveillance or interventions have a potential medical advantage 
then there are clear benefits to predictive testing. The genetic information allows 
the person and their health professional to implement interventions at the earliest 
possible opportunity. 
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An example of an autosomal dominantly inherited genetic condition for which 
pre-symptomatic testing and pre-symptomatic beneficial medical interventions are 
available is familial adenomatous polyposis (FAP).19 A person with the inherited 
mutation for FAP develops many polyps in their bowel, generally by their late teens. 
Without treatment some of these polyps will develop into cancer. Bowel cancer due 
to FAP often occurs in the third, fourth or fifth decade of life, but sometimes even 
earlier.20 When a person is identified as having the mutation, regular surveillance via 
colonoscopy can detect the appearance and growth of polyps, potentially allowing 
them to be removed before cancer develops; or detect the early signs of cancer, 
allowing treatment to begin at the earliest possible opportunity (surgery to remove 
the cancer or bowel, radiotherapy or chemotherapy). More than 90 per cent of bowel 
cancers can be cured if picked up at the earliest stage.21 There is thus potentially great 
clinical benefit in pre-symptomatic testing for the genetic mutation responsible for 
FAP, and other disorders for which there are pre-symptomatic beneficial medical 
interventions available. 
If a disorder cannot be prevented or delayed and there are no medical interventions 
available before symptoms appear then there may be no clinical benefit to testing 
being undertaken pre-symptomatically (even if there are interventions available 
once symptoms appear). That is, testing can be delayed until a person becomes 
symptomatic. 
And yet there may be other non-medical benefits to pre-symptomatic testing for a 
genetic disorder for which there is treatment available (either before or after a person 
becomes symptomatic). Many of these may accrue regardless of whether the test 
results are positive for the genetic mutation, or mutation negative. 
However, pre-symptomatic testing for a disorder for which there are medical benefits 
available (whether pre- or post-symptomatically) also has the potential to cause 
harm.
See Tables 1 and 2 for a list of the purported non-medical benefits and harms in 




–  Enhanced autonomy: minors 
develop their competence, 
confidence and autonomy by 
making increasingly important 
decisions about their lives for 
themselves. A minor needs the 
opportunity to practice and refine 
decision-making skills: testing helps 
to increase the sense of the self as an 
active participant in life, rather than 
a powerless victim of adults and 
genes.22 Granting choice and control 
has a positive value for adolescents 
and respecting their choices has 
positive consequences for their self-
esteem and psychological health.23 
The genetic testing process can 
empower minors.24 
–  The self-knowledge gained from 
the test results can also ‘promote 
more autonomous decision 
making about one’s life’.25 
–  Confronting pre-symptomatic 
testing can result in a minor 
moving through the ‘rebellious 
teenage’ stage more quickly.26 
–  Testing relieves the uncertainty and 
anxiety of not knowing whether 
one carries a genetic mutation 
that will result in a late-onset 
disorder.27 It may remove a mental 
block, and eradicates one of the 
unpredictabilities associated with 
the condition for which one is 
being tested.28









–  Knowing that the genetic 
condition will not 
develop.
–  Being able to stop 
worrying.
–  Relief from anxiety about 
possible early signs of 
disorder.38
–  Feeling freer, able to plan 
and excited about the 
future.39 
–  Positive psychological 
effects include enjoying 
life more; feeling more 
outgoing; feeling more 
normal; feeling happier; 
increased self-esteem; 
and feeling as though a 
new life has been given.
–  Feeling that children 
are a possibility and not 
having to worry about 
them developing the 
condition.
–  Knowing that partners 
will not be burdened by 
the genetic condition in 
the future.
–  Allowing parents to stop 
worrying and seeing 
parents happy. 
– Feeling more able to help 
gene-positive parents.
–  Establishing new 
relation-ships with 
people in similar 
situations.41
–  Allows time for 
research and 
adjustment.42
Potential benefits regardless of  
test result
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– Testing involves a direct encounter 
with a trained professional who 
can transmit accurate information 
directly and supplement complete 
reliance on parental transmission 
of information.29 
– Testing  minors at their request 
allows them to psychologically 
adjust to the information at an 
age-appropriate time. It has been 
argued that ‘being informed of a 
serious illness at an early age may 
facilitate adjustment and coping’.30
– Testing gives the minor the 
opportunity and time to plan 
for the future in view of the 
genetic information (including 
career and financial planning, 
and reproductive and end-of-life 
decisions).31 
– Testing process can improve 
relationships with family members, 
including parents and siblings, as a 
result of opening communication; 
having a reason to spend more 
time with family members; 
realising how strong parental 
support is; and helping siblings 
through the same process. 32
– Testing process can also improve 
and strengthen friendships.33 
– More accurate genetic counselling 
becomes possible.34
– Testing provides opportunity 
to deal with many issues in the 
genetic counselling sessions.35 
– Testing whilst a minor can mean 
that the person tested is young 
enough for the results not to have 
great impact.36 
– Knowing that the 
condition stops now in 
the family.
– Cessation of being treated 





–  Knowing that the genetic 
condition could be fatal54 
–  Negative psychological effects, 
such as worry about the onset 
of the genetic condition; feeling 
shocked; feeling angry; feeling 
depressed; feelings of despair; 
thinking ‘why me?’;55 low self-
esteem; or serious psychological 
maladjustment.56 57 
–  The adolescent process of 
establishing a personal identity 
might be made particularly 
difficult by a mutation-positive 
test result.58
–  Watching parents become 
upset.59 
–  Watching a symptomatic parent 
as an affected individual. 
–  The test result resurfacing when 
other things go badly in life. 
–  Concern about not being able 
to perform at work, or about 
being fired. 
–  The minor and/or family 
might develop a perception 
that the minor is already ill 
and vulnerable or a victim60 
(dietary, environmental or 
other ‘health’ interventions 
might be implemented in an 
effort to stave off the disorder; 
or fewer resources might be 






Potential harms more 
specifically associated with 
mutation-positive result
Potential harms regardless  
of test result 
–  Testing process and test 
results can mean taking time 
off school and can interfere 
with school work. 
–  Anxiety and stress whilst 
waiting for test results.
–  Counselling prior to testing 
and disclosure of test results 
dragging on.  
–  Regrets about being tested. 
–  Negative psychological 
effects after receiving test 
result such as feeling flat or 
lost and not knowing how 
to proceed.
–  Wanting more contact 
with the counsellor than 
provided after receipt of test 
result.  
–  The information may be 
misunderstood which can 
lead to misconceptions 
about the future. 
–  Being too young to 
understand what the test 
entailed. 
–  The possibility of mistaken 
paternity being identified. 
–  Testing during adolescence 
 might interfere with natural 
separation process that 
needs to occur between 
parents and children, 
because of a bond between 
–  Believing that 
one’s own test 
result implies a 
specific result in a 
sibling.  
–  Feeling concerned 
about affected 
siblings.  
–  Feeling concerned 
about having 
to look after an 
affected sibling or 
parent later in life. 
–  Feeling guilty 
about not being 
affected when 
siblings or parents 
are affected.  
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–  Minor might be discriminated 
against or scapegoated within 
the family because parents 
are reminded of their own 
unacceptable traits.61
–  Affected minor may be forced 
into the realisation that her 
parents are not ‘all-powerful’ 
and weare unable to prevent the 
genetic condition. This could 
be psychologically damaging if 
occurring too early in life.62
–  Minor may not want to identify 
with sick family members.63 
–  Disclosure of test results 
to others, including family 
members, resulting in loss of 
privacy.64 
–  Stigmatisation in the family 
and community, with reduced 
opportunities for education, 
marriage and reproduction.65 
–  Minor might find it difficult 
to integrate with peers because 
of feeling different, and 
not desirable for dating or 
marriage.66
–  Parents may not be able to 
help with the impact of the 
test result because of their own 
issues, or guilt over genetic 
inheritance.67
–  Social discrimination regarding, 
for example, employment and 
access to insurance.68 
 an affected minor and 
affected parent, or because 
of guilt over not being 
affected when one’s  
parent is. 
–  Feeling distanced from 
parents who do not share 
the same genetic status.  
–  Drifting apart from parents. 
–  Feeling angry about manner 
in which and to whom 
results were disclosed.
–  Anxiety about others 
learning test result, and 
their possible reactions and 
potential for gossip. 
–  Being treated differently 
and feeling let down by 
unsupportive friends. 
–  Desire for time alone 
affecting friendships. 
–  Having to provide 
explanations about genetics 
to friends.
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There are thus a variety of purported benefits and harms related to pre-symptomatic 
testing for a disorder for which beneficial medical interventions are available. 
The magnitude of some of the potential benefits and harms listed in Tables 1 and 2 
will be affected by the type of medical benefit available for the particular disorder 
for which the minor has been tested. The potential psychological harm involved in 
discovering one will manifest a disorder later in life may be minimised if the disorder 
is curable, as opposed to a debilitating, degenerative disorder for which the only 
beneficial medical intervention available is treatment to ameliorate the symptoms. 
2.3.2.3  Pre-symptomatic testing for late-onset disorder for which there are no beneficial  
 medical interventions
Is a pre-symptomatic test for a late-onset disorder, for which there are no beneficial 
medical interventions available, beneficial or harmful to a competent minor requesting 
such a test? Where there are no pre-symptomatic, beneficial medical interventions 
available (no prophylaxis, no cure and no treatment which will suppress or ameliorate 
the symptoms) then there is no medical benefit to pre-symptomatic testing.69 
HD is an example of an autosomal, dominantly inherited, late-onset disorder for which 
there are no beneficial medical interventions available. HD is a neurodegenerative 
condition with an age of onset generally between thirty and fifty. Early symptoms 
include involuntary movements in the body and limbs, personality changes including 
irritation, poor insight, depression, withdrawal, euphoria and difficulty with 
organisation. Eventually, speech becomes slurred, swallowing difficult and walking 
unsteady. HD sufferers often succumb to a respiratory illness or complications from 
falls.70 
Despite the fact that there are no clinical benefits to testing, the same potential non-
medical benefits may accrue as those listed in respect of pre-symptomatic testing 
for a disorder for which there are medical interventions available (such as enhanced 
autonomy; reduced uncertainty; direct encounter with a trained professional; time to 
adjust; opportunity and time to plan for the future around the genetic information; 
and improved and strengthened family relationships and friendships).
However, it may be argued that there is greater potential for harm in respect of testing 
for a disorder for which there are no possible medical interventions compared with 
testing for a late-onset disorder for which medical interventions are available. The same 
harms as listed may be consequent on such testing, but with a greater likelihood of more 
psychological harm: almost all of the purported harms listed might be exacerbated by 
the knowledge that no beneficial medical interventions are available. Knowing one will 
develop an entirely untreatable disorder later in life could result in extreme despair or 
depression, and ‘cause worse problems than continued uncertainty’.71 
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Additionally, an early diagnosis could result in increased tests, monitoring and 
treatment regimens (at a cost) with no proven benefits.72
2.3.2.3  Susceptibility testing for late-onset disorder for which there are beneficial   
 medical interventions
Is a susceptibly test for a late-onset disorder that can be treated beneficial? There 
may be pre-symptomatic clinical benefits to such testing. For example, testing for 
familial hypertrophic cardiomyopathy (associated with increased risk of sudden 
death) allows drug therapy to prevent arrhythmias;73 and for a number of conditions 
(e.g. familial hyperlipidemia) preventative advice can be given about lifestyle changes 
which have therapeutic advantages.74 Predictive testing for the genetic mutation that 
predisposes people to haemochromatosis (chronic disorder involving the excessive 
absorption and inappropriate storage of iron)75 can yield beneficial clinical results: 
organ damage can be prevented by beginning venesection (the removal of blood) as 
soon as possible. The earlier that venesection begins, the better the prognosis. People 
who are diagnosed with haemochromatosis and who begin venesection prior to 
developing liver damage can enjoy a normal life expectancy.76 
Predictive testing for a BRCA 1 or BRCA 2 mutation that predisposes a woman to 
breast and ovarian cancer might also have useful clinical benefits including increased 
surveillance by the woman and her health professional, or even prophylactic surgery, 
where such is deemed appropriate. The earlier a cancer is found the more successful 
the treatment is likely to be.77 
Many of the disorders for which susceptibility testing can be undertaken are 
multifactorial. That is, there are a number of factors that influence whether or not the 
person will develop the disorder: a faulty gene is not the only cause of the disorder. 
There may be more prophylactic measures available than for genetic mutations 
with 100 per cent penetrance, e.g. dietary, environmental or other lifestyle changes 
or surgery to remove potentially affected areas (e.g. breasts, ovaries or bowel) to 
minimise the risk of developing the disorder. Surveillance aimed at early detection 
may also have great potential to minimise the harm caused by the disorder. However, 
a great deal remains unknown about the other factors that trigger the onset of the 
types of disorders discussed. 
In terms of non-medical benefits, similar issues arise as for pre-symptomatic testing 
for late-onset disorders for which there are available medical interventions. Many of 
the same benefits may accrue. 
For	a	rational	person	wishing	to	pursue	rational	life	plans,	knowing	whether	she	




pregnant.	 Knowing	 that	 she	 is	 a	 BRCA	 1	 mutation	 carrier,	 she	 might	 decide	
against	a	long	university	education	to	have	children	early	and	pursue	a	university	
career	after	having	had	bilateral	mastectomy	and	oophorectomy.78
However, some of the potential benefits gained from pre-symptomatic testing (i.e. 
for mutations with 100 per cent penetrance) are reduced or do not apply in respect 
of susceptibility testing. Susceptibility testing cannot remove the uncertainty to the 
same extent, unless the result is mutation negative. Even if a person tests positive 
for the mutation in question then it is still not known whether or not the disorder 
will develop – only that there is increased risk. This lack of certainty also reduces 
the potential degree of benefit in being able to plan one’s future around the genetic 
information revealed. 
Similar harms might be attendant upon susceptibility testing for treatable disorders 
as those that arise in the context of pre-symptomatic testing. Additional harms may 
also arise in the context of susceptibility testing. The fact that the person may never 
develop the disorder adds a unique layer to the potential harms: many of the harms 
listed may be suffered unnecessarily. That is, the person’s psychological health and 
happiness, chances of obtaining life or health insurance and employment prospects 






However, the purported harms involved in susceptibility testing for a treatable late-
onset disorder may be mitigated by the knowledge that one may never develop the 
relevant disorder: a positive test result for the genetic variation is not a definite 
sentence regarding the disorder (as it is in the case of pre-symptomatic testing). 
Again, the magnitude of the potential benefits and harms will be affected by the type 
of medical benefit available for the particular disorder: amelioration or suppression 
of symptoms, or cure. The degree of susceptibility to the disorder will also be 
relevant: there may be more harm attendant upon knowledge of a 90 per cent chance 
of developing the disorder, for example, than a 20 per cent chance. 
Penetrance is often age related. For example, it is estimated that the cumulative risk of 
breast cancer for women with BRCA 1 mutations is around 3.2 per cent by age thirty, 
16 per cent by age forty, 59 per cent by age fifty and 82–85 per cent (approximately) 
by age seventy.80 
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2.3.2.4  Susceptibility testing for late-onset disorder for which there are no beneficial   
 medical interventions
Is a susceptibility test for an untreatable late-onset disorder beneficial? Where there 
are no pre-symptomatic, beneficial medical interventions available (no prophylaxis, 
no cure and no treatment which will suppress or ameliorate the symptoms) then 
there is no medical benefit to susceptibility testing.
Alzheimer’s disease is an example of a multifactorial late-onset disorder (which 
is thought to have a heritable genetic basis) for which there are only very limited 
beneficial medical interventions available (medications to slow the decline). 
Alzheimer’s disease involves ‘gradual memory loss, decline in ability to perform 
routine tasks, disorientation in time and space, impairment of judgment, personality 
change, difficulty in learning and loss of language and communication skills’.81 The 
age of onset and rate of disease progression varies, and the life span from onset can be 
anywhere from three to twenty years. The disease eventually leaves sufferers unable 
to care for themselves.82 
Some of the same potential non-medical benefits may accrue as for pre-symptomatic 
testing for the other kinds of disorders: the positive psychological effects of a mutation-
negative result; testing pursuant to the minor’s request enhancing autonomy; and 
testing enabling psychological adjustment. 
Fewer non-medical benefits may apply in respect of susceptibility testing for an 
untreatable late-onset disorder. Unless the result is mutation negative, the anxiety 
involved in ‘not knowing’ may not be mitigated and the potential benefit in being 
able to plan better for the future is reduced. 
Similar harms might be attendant upon susceptibility testing for an untreatable late-
onset disorder as for pre-symptomatic testing for an untreatable late-onset disorder. 
There may be greater potential for psychological harm in respect of testing for a 
disorder for which there are no medical benefits. Knowing one is at a significantly 
increased risk for an untreatable late-onset disorder could result in extreme despair 
or depression. 
Again there is the additional mischief that these more severe harms may be suffered 
unnecessarily, as the person may never develop the disorder. 
Conversely, the harms involved in susceptibility testing for an untreatable late-onset 
disorder may be somewhat mitigated by the knowledge that one may never develop 
the relevant disorder: again, a positive test result for the genetic variation is not a 
definite sentence (as it is in the case of pre-symptomatic testing). 
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The magnitude of the potential benefits and harms may be affected by the degree of 
susceptibility to the disorder. There may be more harm in knowing that one has a 90 
per cent chance of developing the disorder as opposed to a 20 per cent chance. 
2.3.3  Carrier testing
It is important to distinguish carrier screening from carrier testing, at this juncture. 
This section of the report focuses on testing of ‘at-risk’ individuals, and not screening 
of large groups or populations. Carrier screening usually refers to testing programmes 
involving large groups of people, who may or may not be individually ‘at risk’ for the 
disorder tested for,83 and raises political, legal, cultural, social and economic issues 
that do not necessarily arise in respect of testing ‘at-risk’ individuals for carrier 
status. 
For the individuals tested, there are generally no medical benefits to carrier testing.84 
However, the test results do allow the individual to make more informed reproductive 
choices.85 Many of the purported benefits are also relevant to carrier testing (with a 
change in terminology and shift in focus from developing a disorder to knowing 
one’s offspring may develop a disorder). The benefits relating to future planning, 
particularly around reproductive decisions, are of great significance in the carrier-
testing context. The purported benefit of being tested at an age-appropriate time 
is also of particular weight. The competent minor requesting testing may well be 
considering embarking on a sexual relationship, and may require knowledge of 
carrier status in order for sexual behaviour to be as informed as possible. 
Fanos argues that siblings of affected individuals may view their carrier status as a 
benefit in terms of being able to feel a part of the disorder community, like others in 
the family, and feeling closer to the sibling with the disorder. Additionally, carriers 
may feel less survivor guilt if they perceive that they are sharing the burden of the 
condition.86 Being a carrier means that the ‘unaffected’ individuals are also affected to 
a certain extent (usually primarily in respect of reproductive choices) by the disorder 
and thus may not feel as guilty as if they had entirely escaped the burden of the 
disorder from which their siblings suffer. 
However, that is not to say that psychosocial harms do not exist in respect of carrier 
testing. The possibility of feeling, or being, stigmatised is real, and carrier testing 
may have a unique ability to evoke fear of intimacy and interpersonal relationships, 
relating as it does to sexual relations and reproductive choices.87 
Additionally, it has been suggested that carrier testing may lend itself to particular 
potential for misunderstanding the implications of the test results, being a medical 




Some consider carrier testing to be less serious, or less harmful, than predictive 
testing of minors,90 because the individual tested will not develop the disorder, and is 
‘only’ at risk of passing on the disorder. 
Some of the purported harms are not applicable or are arguably less threatening 
in respect of carrier testing. For example, knowing that the genetic condition, for 
which one has tested positive, could be fatal is not strictly applicable to unaffected 
carriers (although it may be to their potential offspring); watching a symptomatic 
parent as an unaffected carrier may not be as psychologically harmful as watching 
a symptomatic parent as an affected individual given that one will not develop the 
disorder oneself; access to and concerns regarding education, employment and 
insurance are not as salient; and it is arguably less likely, if everybody is adequately 
informed, that a carrier will be treated as vulnerable, or as a victim, than will be the 
case for a pre-symptomatic affected individual. 
Hogben and Boddington take issue with the distinction frequently drawn between 
testing minors for carrier status, and testing them for late-onset disorders.91 They 
argue that the distinction rests on an assumption about the status of reproduction 
in people’s lives, and on an ethical stance that prioritises the self over others.92 They 
criticise the implicit assumptions that reproductive issues are ‘of relatively minor 
import’ compared with issues related to one’s own health status; and that issues 
that concern others (such as the ‘next generation’) are relatively minor compared 
with issues that concern oneself. They argue that carrier status may be of profound 






Hogben and Boddington highlight the fact that the focus on the implications of 
carrier testing for reproductive decisions means that ‘the potential implications for the 
reproductive self, which result from predictive testing, are routinely overlooked’.94
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2.  Purported harms of not testing on a competent minor’s request
Clinical or physical harms can arise partly as result of not having a genetic test. For 
example, a person affected by the FAP mutation will almost certainly develop cancer 
if the polyps in the bowel are not detected early enough. In cases where there is a clear 
medical benefit to predictive testing, and conversely likely harm consequent upon 
not testing, one would expect that testing would go ahead. That issue is relatively 
non-controversial. But there may also be harms in not performing tests where the 
medical benefit is not so clear-cut. 
Professional guidelines, position statements and opponents of genetic testing do not 
often refer to the potential (non-medical) harms that may arise from refusing to 
provide a competent minor with a predictive genetic test upon request.95 






2.4.1  Potential non-medical harms of not testing – All kinds of genetic testing 
Many of the harms that may potentially arise from not testing a competent minor 
who is requesting a genetic test are the converse of the potential benefits. For example, 
refusing to test may:
•	 Restrict development of and diminish confidence, decision-making ability, 
competence and autonomy;
•	 Limit the minor’s self-knowledge (which would have been enhanced by 
information given via the test result) and thereby further diminish autonomy 
and decision-making capabilities;
•	 Prolong the uncertainty and anxiety of not knowing whether one carries a 
genetic mutation that will result in a late-onset disorder or that one could pass 
on to one’s offspring;
•	 Limit the time available to adjust psychologically to the information at an age-
appropriate time;
•	 Deny minors the opportunity and time to plan their futures around the genetic 
information (given that many minors make career and other life plans in 
adolescence);
•	 Prolong family and friendship tensions; 
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•	 Limit the opportunity for reflection, communication and information gathering 
that is encouraged in genetic counselling; 
•	 Delay the psychological benefits consequent upon finding out one does not have 
the genetic mutation tested for;
•	 Delay reproductive decisions; and
•	 Prolong concerns about how partners, potential partners, parents, siblings, 
friends, family members and wider groups might react to the test result. 
Other harms may arise from not testing, which amount to more than simply the 
denial of the potential benefits referred to earlier. 
For example, refusing to test may:
•	 Frustrate the minor seeking testing and result in feelings of unworthiness;
•	 Result in or prolong risk behaviours in minors who know that they are at risk 
for a heritable genetic condition;
•	 Prolong the period in which minors assume and act as though they have the 
genetic mutation. Living as if one has a condition can bring with it almost all of 
the harms associated with actually having the condition.97
…	 the	 decision	 to	 postpone	 testing	 can	 never	 be	 taken	 lightly.	 The	 stress	 of	
undergoing	testing,	receiving	a	result,	and	adjusting	to	the	new	risk	status	must	
be	weighed	against	the	stress	and	uncertainty	of	living	at	risk	for	HD,	the	blow	
to	 the	candidate’s	 self-respect	by	being	denied	testing	and	the	possible	 sense	of	
humiliation	and	helplessness	by	having	one’s	autonomy	undermined.98	
As with the purported harms and benefits of genetic testing, there is a lack of empirical 
evidence regarding the purported harms of not testing, especially in minors. The 
existing evidence of harms and benefits and the relevance of a lack of such evidence 
are considered in the next section in the context of each type of genetic test.
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2.  evidence of benefits and harms, or lack thereof
2.5.1  Predictive testing
There is a little evidence-based information about the psychological and social effects 
of predictive genetic testing in children, including competent minors.99 Much of the 
discussion is based on speculation: some of the purported benefits and harms are 
imported from research involving predictive genetic testing of adults, and some are 
analogised from other medical contexts.100 
There have been very few studies into the psychological and social effects of predictive 
testing in minors. Of the few that exist, some refer to particularly small case studies 
involving one or two very young children, and relate mostly to parental responses to 
testing.101
Johnson studied the emotional and cognitive effects of testing for a diabetes predictor 
on fifteen children and twenty-one adults. She found that children, like adults, 
exhibited clinically significant anxiety when first told they were at risk, but returned 
to normal levels within two or three months.102
A Canadian team of researchers studied the behavioural effects of testing minors 
aged four to seventeen years for hyperlipidemia (elevated or abnormal levels of 
lipids or lipoproteins in the blood).103 While no differences were found in anxiety, 
depression, social competence or behavioural adjustments between the thirty-four 
minors who tested positive and the twelve who tested negative, mothers reported 
more behavioural problems in the positive children.104 However, as Michie and 
Marteau point out, it is unclear the extent to which reported behaviour reflected 
actual problem behaviour, or increased sensitivity on the part of parents.105 
There are larger studies relating to predictive testing of young people for the FAP 
mutation.
Codori et al. studied the short-term psychological effects of genetic testing for FAP 
by surveying forty-one children (aged six to sixteen years) and their parents, before 
testing and three months after testing.106 
Minors’ mean scores for depression, anxiety and behavioural problems were 
in the normal subclinical range both before and after testing, ‘suggesting that 
children tolerated genetic testing for FAP without clinically significant increases in 
psychological distress or deterioration in adaptive behaviour’.107 Indeed, all minors 
showed a significant decrease in behavioural problems following testing.108
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Minors with affected mothers had subclinical yet significant increases in anxiety, 
regardless of their own test result. They also had subclinical but significant increases 
in depression if their mothers were affected and they themselves received a gene-
positive result.109 
Michie, Bobrow and Marteau addressed two questions in their study into the 
emotional impact of predictive genetic testing for FAP in children and adults: (1) Do 
children or adults receiving positive test results experience clinically significant levels 
of anxiety or depression? (2) Do children receiving positive test results experience 
higher levels of anxiety or depression than adults receiving positive results?110 
They measured the anxiety and distress levels of sixty minors (aged ten to sixteen) 
who were tested for the FAP mutation, and compared them with the same measures 
in 148 adults (aged seventeen to sixty-seven) who were also tested for the same 
mutation.
They found that the children (both those who received mutation-positive results 
and those who received mutation-negative results) had depression and anxiety levels 
and behavioural problems within the normal range. In contrast, 43 per cent of the 
adults who received mutation-positive results displayed clinically significant levels 
of anxiety.111 
The authors argue that some possible explanations for the anxiety difference 
between children and adults are not supported by the data. Some might suggest that 
the children did not understand the meaning of the positive test result. However, 
children with positive results perceived a higher chance of getting polyposis, worried 
more about that chance and were more threatened by their test results than those 
who received negative results. Others might argue that the children did not perceive 
polyposis to be as serious as the adults did. However, there was no difference between 
children and adults as to how bad they considered polyposis to be, or how bad they 
thought it would be if they developed it.112 
Another possibility was that children might express their anxiety behaviourally, rather 
than by self-report. However, parents’ reports did not suggest that mutation-positive 
children had any more behavioural problems than average. The authors suggest that 
children may have less understanding of the social implications of the test result, 
such as obtaining a mortgage or insurance, and the reproductive implications. 
Alternatively, they may find the implications less threatening because they will arise 
in the future. However, the data did not support that contention either. Mutation-
positive children did find their results more threatening than mutation-negative 
children; and Codori et al. found that, among children aged six to sixteen, age was 
not associated with anxiety, depression or behavioural problems.113
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With regard to the course of anxiety in children over the first year after testing, 
children who received mutation-positive results did not show increased emotional 
distress after receiving their results, and their anxiety, depression and self-esteem 
scores were within the normal range and did not change over time. There were 
trends for children with positive test results to be more anxious and depressed than 
those who received negative results, and for a higher number of the former to be in 
the clinical range of anxiety. Minors who received a negative test result displayed 
decreased anxiety and increased self-esteem, and worried less about their chance of 
getting polyposis.114 
The authors conclude that:





In a further study Codori et al. assessed symptoms of depression, anxiety and 
behavioural problems in forty-eight minors between the ages of five and seventeen 
years (forty-one of whom had also participated in the study outlined earlier) tested 
for the FAP mutation, for up to four-and-a-half years after testing. Twenty-two of the 
minors were mutation positive, and twenty-two were mutation negative.116 
Across all follow-up periods there were no clinically significant changes in the minors’ 
psychological tests scores, regardless of test results. Behavioural problems decreased 
for all children.117 
This study added to the factors analysed in the previous study by assessing the effect 
of a mutation-positive sibling on the children’s psychological outcomes. There were 
subclinical, but significant, increases in depression symptoms amongst minors who 
tested positive and also had a mutation-positive sibling, and several mutation-negative 
children with mutation-positive siblings displayed clinical elevations in anxiety.118 
Duncan contends that this ‘(minimal) body of empirical research … reports a largely 
beneficial group of experiences’ as a result of predictive testing of minors for the FAP 
mutation, including decreases in anxiety and behavioural problems.119 
However, Duncan criticises the narrow range of potential benefits and harms focused 
on in studies about predictive testing in minors (depression, anxiety and behavioural 
problems), and further contends that the majority of outcomes researched have been 





Pre-symptomatic genetic testing for HD has been available for longer than predictive 
testing for any other heritable genetic disorder,121 giving rise to studies on the longer-
term implications of testing.122 
Duncan reviews the literature on the effects of predictive testing of adults for HD, 
to gain an impression of the possible effects of pre-symptomatic testing of minors 
for untreatable late-onset disorders (as opposed to pre-symptomatic testing for FAP, 
which has medical benefits).123 
Regarding evidence of predictors of how individuals will react after predictive HD 
testing: individuals’ negative feelings prior to testing (e.g. avoidance of HD-related 
situations, and dissatisfaction) were often exacerbated post testing (e.g. avoidance 
behaviour, depression, suicidal thoughts); although feelings of anxiety were often 
assuaged after testing. ‘Test result, age and gender have been shown to be bad 
predictors of reactions after testing.’124 
Duncan concludes that fears that predictive testing for the HD mutation would have 
catastrophic effects have not materialised.





However, Duncan does note the need for caution in applying the results of the studies: 
all of the people studied were persons who voluntarily underwent the predictive test. 
Those people might be more psychologically resilient than others who choose not 
to undergo testing, or those who dropped out of the studies (recent research having 
revealed that those who drop out of research studies generally have higher levels 
of psychological distress, evaluated prior to drop out). Additionally the most long-
term research results published indicated that pessimism may begin to grow amongst 
those with mutation positive test results, as the onset of the HD approaches. However, 
Duncan argues that this pessimism may in fact be related to the early symptoms of 
HD, so further research was required.126





beneficial.	We	may	also	extrapolate	 these	findings	 to	assume	 that	predicting	a	




2.5.1.1  Predictive genetic testing of young people for non-medical reasons128 
Duncan et al. surveyed 301 respondents from the United States, Canada, the United 
Kingdom, Australia and New Zealand who were professionally involved in predictive 
genetic testing. They were questioned as to their involvement in relation to predictive 
genetic testing of minors for untreatable conditions, including any follow-up pursued 
post testing, and outcomes recorded.
Thirty-six clinicians (12 per cent) had been involved in providing predictive genetic 
tests for untreatable conditions to young people. There were forty-nine cases of such 
testing, in relation to fourteen different conditions. Of the twenty-seven cases (55 per 
cent) of testing of mature young people (fourteen or older), the majority (eighteen) 
involved minors aged sixteen to seventeen. 
The most common condition young people were tested for was HD (fourteen cases). 
Other conditions tested for included myotonic dystrophy (the most common adult 
form of muscular dystrophy),129 breast cancer predisposition and spinocerebellar 
ataxia (‘characterised by slowly progressive incoordination of gait and often associated 
with poor coordination of hands, speech, and eye movements’).130
In four cases (15 per cent) the young person’s parents requested the testing, and in 
ten cases (37 per cent) the young person requested testing. In the remaining thirteen 
cases (48 per cent) the request for testing came from both the young person and 
the parents. Results were disclosed to all of the mature young people, except for one 
intellectually disabled fourteen-year-old. 
Two thirds (18/27) of the cases of mature young people who had been tested were 
followed up, in a variety of ways. Two adverse events were reported: one seventeen-
year-old male found to be at increased risk for HD was initially depressed and 
rebellious, but eventually accepted the result; and one seventeen-year-old female who 
was free of the HD mutation felt ‘worry and responsibility for affected mother and 
untested brothers’. 131
There were also nine reported beneficial effects: six following decreased risk results 
(‘enabled him to focus on school’, ‘negative result really helped to stabilise life’); and 
three following increased risk results (e.g. ‘So far she is doing fine and seems to have 
integrated this information into her thoughts about her future in a healthy way’ and 
‘Coped better than many twenty-year-olds’).132
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2.5.1.2  Duncan – Holding your breath: Predictive genetic testing in young people
Duncan interviewed ten young people who had undergone predictive testing for FAP 
(participation rate of 20.8 per cent) and eight young people who had undergone 
predictive testing for HD (participation rate of 38.1 per cent).133 
Of the ten respondents interviewed regarding testing for FAP, four were male, six 
were female, half were mutation positive, and half mutation negative. At the time of 
testing their ages ranged from ten to seventeen, and at the time of interviewing their 
ages ranged from fourteen to twenty-five.
Of the eight respondents interviewed regarding testing for HD, four were male, four 
were female, two were positive for the HD mutation and six were negative. At the 
time of testing their ages ranged from seventeen to twenty-five, and at the time of 
interviewing their ages ranged from twenty to twenty-six.
Duncan is well aware that ‘The fundamental difference between these two types of 
predictive genetic tests is the existence (or lack) of medical benefit as a consequence 
of the test’.”  
When	young	people	undergo	predictive	genetic	testing	for	FAP	they	do	so	because,	
if	 found	 to	 be	 gene-positive,	 they	 are	 able	 to	 engage	 in	 preventative	 measures	




However, she argues that: 
…	 the	 existence	 of	 medical	 benefit	 as	 an	 outcome	 of	 predictive	 genetic	 testing	
does	not	negate	the	potential	for	harm.	It	simply	overrides	this;	and	the	absence	








She therefore does not separate these two types of experiences when conveying the 
descriptions given to her by the young people that she interviewed.136
As a result of her interviews with young people who had undergone predictive genetic 
testing Duncan provides empirical evidence of many of the purported benefits and 
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harms referred to earlier. The evidence is from young people who have been through 
predictive genetic testing, and is not merely conjecture.
2.5.1.3  Evidence of benefits of predictive genetic testing regardless of test result
• Enhanced confidence: one young person reported feeling ‘nice and   
 important’ because his signature was required for the procedure, rather than  
 his mother’s;137 another said that he respected himself a lot more after   
 genetic testing, and realised that he could do anything.138 
• Self-knowledge gained from results promoted more autonomous decision- 
 making: young people intimated that they had made career plans around   
 the genetic information.139 Related, Wertz has also written that several   
 young women who had been tested for carrier status for Fragile-X in their  
 teens reported that they were grateful for the test, because results showing  
 that they were carriers helped to not only explain their poor performance in  
 school, but also enabled them to plan their future careers.140 
• Minors moved through the ‘rebellious teenage’ stage more quickly,   
 apparently as a result of learning their genetic status, including getting off  
 drugs and getting into less trouble with the police.141 
• Testing relieved the uncertainty and anxiety of not knowing.142
• Testing allowed psychological adjustment at an age-appropriate time. One  
 young woman indicated that she was only fifteen when she was tested and  
 her attitude had been to worry about the here and now, rather than the   
 future: ‘at least I know … at least my parents know and don’t worry  
 about it’.143 
• Testing gave minors the opportunity and time to plan their future: after   
 testing, some felt more comfortable talking about the future.144 
• The testing process improved relationships with family members, and often  
 parents in particular.145 
• Testing impacted positively on some friendships.146 
• Testing gave some minors the opportunity to deal with many issues in the  
 genetic counselling sessions.147






2.5.1.4  Evidence of benefits more specifically associated with a mutation-negative result




 • Being able to stop worrying.150
 • Feeling freer, able to plan and excited about the future.151 







 • Feeling that children are a possibility and not having to worry about them  
 developing the condition.155
We	didn’t	want	to	have	children	if	they	had	the	gene,	ah,	cause	we	didn’t	
want	to	pass	it	on…but,	yeah,	now	we	do	…156	
 • Allowing parents to stop worrying and seeing parents happy.157 
 • Feeling more able to help gene-positive parents.158
 • Knowing that the condition stops now in the family.159 
2.5.1.5  Evidence of benefits more specifically associated with mutation-positive result
	 •	 Establishing new relationships with people in similar situations.160
2.5.1.6  Evidence of harms regardless of test result
 • Testing process can mean time off school and can interfere with school work.161
 • Anxiety and stress whilst waiting for test results.162
 • Counselling sessions dragging on: one young person indicated that she   
 had just wanted to be tested, rather than to go through continual counselling 
 sessions.163 





 • Negative psychological effects, including feeling really lost.165
 • Wanting more contact with the counsellor than provided after receipt of test  
 result.166
 • Being too young to understand what the test entailed.167
 • Feeling distanced from parents who do not share the same genetic status.168
 • Drifting apart from parents.169 
 • Feeling angry about the manner in which and to whom the results were   
 disclosed, expressed particularly by one young woman who had been told  
 over the telephone that she was positive for the FAP mutation.170 
 • Anxiety about other people learning of the result, and their reactions and   
 potential for gossip.171 
 • Being treated differently and feeling let down by friends who are    
 unsupportive.172 
 • The desire for time alone affecting friendships.173
2.5.1.7  Evidence of harms associated with mutation negative result
 • Believing that one’s own test result implies a specific result in a sibling:
…	cause	it	was	50–50	whether	I	got	it,	I	was	thinking,	because	I	didn’t	have	
it,	is	it	more	chance	[brother]	was	going	to	get	it	and	stuff	like	that	…174
 • Feeling concerned about affected siblings.175
 • Feeling concerned about having to look after an affected sibling or parent.176
 • Feeling guilty about not being affected when siblings or parents are   
 affected.177
2.5.1.8  Evidence of harms more specifically associated with a mutation positive result





 • Negative psychological effects, including increased worry,180 sadness,181 anger, 
 and depression:182 ‘At first, I thought, why me and not him … and it’s not   
 fair.’183







 • The positive test result resurfacing when other things go badly in life.186
 • Concern about not being able to perform at work, or being fired.187
 • One minor indicated that she did not want to identify with sick family   
 members.188
 • Some minors experienced difficulty integrating with peers because of feeling  
 different.189
2.5.1.9  Evidence of harms arising from not testing minors







 • Prolonged the uncertainty and anxiety of not knowing:
…	for	19	years	it	feels	like	I’ve	held	my	breath	…191
 • Limited opportunities and time to plan future, including reproductive   
 decisions.192
 • Prolonged family and friendship tensions.193
















 • Resulted in or prolonged risk behaviours in minors who knew that they   
 were at risk, including bad behaviour at home and at school, excessive   
 drinking, drug-taking and trouble with the police.195 The comments   
 from the young people whom Duncan interviewed accord with the findings  
 from Codori et al.’s two studies of the effects of predictive testing for the   
 FAP mutation, in which all minors showed a decrease in behavioural   
 problems following testing.196 
 • Prolonged the period in which minors assumed they had the genetic   
 mutation.197
There is evidence that adults too, for whatever reason, assume pre-testing that they 




2..2  carrier testing
There is a great deal more evidence about the effects of carrier screening programmes 
than there is in respect of individual carrier testing of people within high-risk 
families.
It is conceivable that some of the evidence about the effects of carrier screening of 
minors might be extrapolated to project likely effects of individual carrier testing of at-
risk minors. However, note that Michie and Marteau have argued that population-based 
screening is associated with more problems than screening of high-risk groups.199 
There is (historical)200 evidence from carrier screening programmes that knowledge 
of carrier status can have adverse effects in adults.201 Clarke provides the following 
review of the evidence:202 
• Stigmatisation or fear of stigmatisation.203
• Adult Tay-Sachs carriers have been shown to be less optimistic about their 
future health.204
• As many as 19 per cent of Tay-Sachs carriers in one study were worried about 
their carrier status years after testing.205
• 10 per cent of sickle-cell and thalassaemia carriers, in a study in Rochester NY, 
also worried about their carrier status.206
• Wider issues of social stigma have caused concern, particularly in relation to 
population screening for sickle-cell carrier status in the United States.207
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• Limited experience with population screening for cystic fibrosis in Britain 
indicates that many adults, even those related to known carriers, decline the 
offer of screening tests.208
The	fact	that	many	adults	who	are	offered	carrier	screening	for	recessive	disorders	





Wertz reports that early findings by Clow and Scriver about the Montreal Tay-Sachs 
carrier screening programme (of adolescents aged fifteen and over) were positive: 
‘These studies suggest that learning that one is a carrier does not ordinarily damage 
self-image or lead to social stigmatization.’210 
An eight-year follow-up questionnaire revealed that adolescents screened in the 
Montreal Tay-Sachs programme were predominantly in favour of having been 
screened. ‘Although 46 per cent of carriers were “worried” after receiving results, the 
majority were “indifferent” eight years later to the knowledge of being a carrier.’211
Further research on the Montreal Tay-Sachs carrier screening programme suggested 
that many adolescents can effectively use genetic information attained during high 
school years in later reproductive decisions. 
This	 analysis	 shows	 no	 negative	 effects	 of	 knowledge	 of	 carrier	 status,	 and	
demonstrates	 that	 adolescents	 both	 remember	 information	 regarding	 their	
carrier	status	and	use	it	in	an	appropriate,	mature	manner.212	
Evaluation of an Australian programme of Tay-Sachs disease and cystic fibrosis 
carrier screening of 629 students (77 per cent of a possible 817 students) between the 
ages of fifteen to seventeen in four private Jewish high schools in Sydney in the late 
1990s, revealed that: 
Three	to	six	years	 later,	 there	was	a	high	retention	of	knowledge,	 low	concern,	




2.  the available evidence from existing research
2.6.1  Predictive testing of minors for the FAP mutation
The evidence from the three studies outlined earlier in relation to predictive testing 
of minors for the FAP mutation214 appears encouraging, in that no major harms 
were associated with testing, even when the test results were mutation positive. Any 
harmful psychological effects reported were mostly subclinical and were associated 
largely with minors who had affected mothers or siblings, often regardless of whether 
or not the minor was actually affected. Thus the issue of whether predictive testing is 
beneficial or harmful to a minor is not so simple as merely looking at the test results 
of the individual. The family context, which may be vitally relevant, is discussed in 
more detail later.
Perhaps the most interesting finding amongst these studies comes from Michie et al. 
Minors who received a positive test result displayed anxiety and distress levels within 
the normal range, while 43 per cent of affected adults displayed clinically significant 
anxiety levels. This finding appears to support the argument that testing during 
adolescence, at a minor’s request, occurs at an age-appropriate time. 
The relevance of these studies on testing for the FAP mutation in the context of a 
competent minor requesting predictive testing is debatable. Many of the children in 
these research studies were young, and were tested on the basis of parental consent, 
rather than their own.215 Codori et al. surveyed children aged six to sixteen in their 
first study, and children aged five to seventeen in the later study. Parents gave informed 
consent for their children to participate in the study, and children assented. Michie 
et al. studied minors aged ten to sixteen, who were tested upon parental consent. 
The circumstances might be different where a minor seeks and consents to testing, 
although the findings are encouraging.
Another concern is that these findings in respect of the effects of testing for the 
FAP mutation may be limited in their application to testing for conditions for 
which beneficial medical interventions are available. The availability of medical 
interventions may well have helped the minors adjust to the news that they had tested 
positive for the mutation (which is not to minimise the seriousness of testing positive 
for the FAP mutation). 
Regardless, testing an at-risk competent minor for the FAP mutation will generally 
be non-controversial given the medical benefits that accrue from testing: increased 
surveillance and early detection for those who test positive; and cessation of invasive 
surveillance for those who test negative.
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2.6.2  Predictive testing for HD in adults
The recorded effects of predictive testing of adults for HD are diverse. There is 
certainly evidence of harms arising from predictive testing, whether test results are 
mutation negative or positive. And yet some would argue, as Duncan has, that fears 
of catastrophic effects as a result of such testing have not materialised. 
Notwithstanding, the literature and the evidence of benefits and harms of predictive 
testing of adults for HD cannot simply be imported into the more general discourse 
on genetic testing of competent minors upon request, not least because HD is a 
unique disorder ‘terrible in its manifestations, progression and fatal outcome’.216 
Additionally, there may be many salient differences between competent minors who 
seek predictive testing for HD and those adults who have been studied in the HD 
literature. Being adults, and not minors, many of the participants had lived with 
their at-risk status for a long time, which may have accounted in part for the massive 
impact experienced even after a mutation-negative result. Also, many of the adults 
studied had already made marital and reproductive choices and thus the benefits of 
testing may not have been as immediately obvious for this group. The age of onset 
was also closer in time for the adults than the minors. The differences between how 
adults and competent minors react to such testing will remain speculative until more 
empirical evidence is gathered.
However, evidence exists of benefits arising from predictive testing of adults for 
HD, even when the results are mutation positive. Of the limited evidence available 
regarding predictors for reactions to such testing, emotions and other baseline 
strengths pre-test are important. ‘Test result, age and gender have been shown to be 
bad predictors.’217 
2.6.3  Duncan’s international survey of clinicians
The responses to Duncan’s international survey of professionals involved with 
predictive genetic testing provided generally positive evidence of outcomes from 
testing of competent minors: two adverse effects were reported, and nine beneficial 
effects. However, Duncan rightly notes that there are questions around how to 
define beneficial and harmful outcomes of genetic testing. It could be argued that 
the two negative outcomes reported (initial depression and rebellion before eventual 
acceptance, and concern for affected mother and untested brothers) were entirely 
normal and appropriate responses, and that the minor’s concern for her mother and 
brothers may well have existed sans testing.218
The significant lack of follow-up of the minors tested (only 50 per cent of the 
younger children tested, and two-thirds of the competent minors, were followed up) 
is concerning, not only because it limits knowledge of the effects of the testing,219 but 
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also because it means that minors and their families may not have been getting the 
necessary follow-up support.
Duncan also notes that clinicians may have under-reported harmful outcomes of 
testing because they had ‘provided tests, contrary to recommendations made in 
current guidelines’.220 Under-reporting of harmful outcomes for this reason may be 
less likely in respect of competent minors because, as is argued earlier, most of the 
current guidelines are open to the testing of competent minors upon request.
Finally, the evidence as to outcomes is questionable given that they were reported by 
the clinicians involved in the testing and not the individuals tested or their families; 
and there were no common definitions or standard criteria for beneficial and harmful 
outcomes against which clinicians could measure outcomes. The questions in respect 
of outcomes simply stated: ‘What has the follow-up shown?’ and ‘Looking back, do 
you think it would have been beneficial for the young person to wait until the age of 
18 years or older to be tested? Why/Why not?’221
However, despite the limitations, the results indicate that, amongst the cohort tested 
and followed up, more benefits than harms accrued as a result of predictive testing. 
2.6.4  Duncan’s research with young people tested for the FAP and HD mutations
Duncan’s study of eighteen young people who had undergone predictive testing for 
the FAP or HD mutation provides empirical evidence of a litany of benefits and 
harms that may accrue from predictive genetic testing. 
However, the sample size was very small, and involved individuals tested for just two 
disorders. Additionally, all of those tested for HD (except one) were at least eighteen 
years of age at the time of testing, and thus the relevance of their responses with 
regard to the effects of predictive testing of competent ‘minors’ may be questioned. 
However, as Clayton and many others have pointed out, minors ‘do not emerge from 
a cocoon at age 18 with full blown decision-making capacity ...’222 And the young 
people tested for HD also provide evidence of the largely negative effects on them of 
being denied testing before the age of eighteen.
In terms of benefits and harms specific to each of the disorders, we recall that 
Duncan discussed the experiences of both kinds of testing together because of her 
‘assumption that the existence of a medical benefit would not negate the potential for 
harm when mature young people undergo predictive genetic tests, just as the absence 
of a medical benefit would not negate the possibility for benefit’.223 








as	 colonoscopies	 and	 surgery.	 …	 the	 meaning	 they	 ascribe	 to	 the	 test	 is	 often	




test	 result	 for	FAP,	a	major	benefit	articulated	by	young	people	was	 that	 they	
would	 be	 able	 to	 prevent	 cancer	 from	 developing.	This,	 understandably,	 often	
overshadowed	other	benefits	such	as	relief	about	knowing	their	genetic	status	or	
feeling	able	to	plan	life	more	effectively.224	
Duncan therefore cautions that ‘we must be mindful of the limitations of using 
empirical evidence relating to tests provided for medical reasons in order to draw 
conclusions about tests provided for non-medical reasons’. 225
Some very positive experiences are revealed in the young people’s comments conveyed 
by Duncan. And despite the evidence of negative feelings also provoked by genetic 
testing, it seems only one of the eighteen young people interviewed expressed regret 
about being tested (and he appears to have been tested at the behest of his parents, 
rather than of his own volition: ‘Dad just organised it, and I just had to come in, get 
the um blood test.’)226 
However, note too the inherent bias (acknowledged by Duncan)227 that all of the 
young people consented to be interviewed, and may have been coping better with 
their genetic testing experience than those who refused to participate in the research. 
Those who were most harmed by the testing may well have refused to talk about it.
2.6.5  Susceptibility testing 
Testing for predisposition to conditions for which the genetic mutation is not 100 
per cent penetrant can add a layer of complexity to analysing the benefits and harms. 
One of the major benefits of predictive genetic testing is the reduction in uncertainty 
that a test result provides. However, susceptibility tests cannot tell someone whether 
they will get the disorder tested for, only whether they are at increased risk (or not) 
for developing the disorder. However, susceptibility tests may reassure those who are 
found not to have the relevant mutation.228 
The fact that one is only predisposed as opposed to certain to develop the disorder, 
and that there are often medical interventions available for multifactorial disorders, 
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does not necessarily make genetic testing a more palatable experience. Some of the 
treatments available, such as removal of the bowel and insertion of a colostomy bag, 
or a double mastectomy or oophorectomy, are far from pleasant. 
If one does choose to undergo genetic testing, and tests positive for a genetic mutation 
that increases one’s susceptibility to a disorder, then the test results could herald just 
the beginning of further difficult decisions. One might consider or undergo extreme 
and potentially unnecessary measures to reduce susceptibility to the disorder, e.g. a 
person found to have a BRCA 1 mutation may have a double mastectomy to reduce 
the chances of developing breast cancer. Being at risk for a mutation that predisposes 
one to developing a disorder is a drawn out, complex and involved multifactorial 
issue: not just a ‘test or no test’ equation. 
The possible sequelae and options provoked by a mutation-positive test result need 
to canvassed before testing is undertaken. The person seeking testing needs to be 
aware of the implications of the test in order to make a fully informed decision. 
2.6.6  Research on the effects of carrier testing
Hogben and Boddington’s argument that protection of autonomy is considered to be 
more pertinent in relation to predictive testing than carrier testing, and that predictive 
testing of children is thereby seen as more serious because it ‘spoils’ their autonomy, 
is not as germane in the context of competent minors who request genetic testing. 
Genetic testing upon a competent request does not ‘spoil’ autonomy regardless of 
the type of test. 
While appreciative of the concerns raised by Hogben and Boddington229 we 
are unconvinced that carrier testing is not in actual fact ‘less serious’, in terms of 
potential harms, than predictive testing for late-onset disorders, not least because 
of the reproductive implications of predictive testing. People affected by a heritable 
genetic mutation can also pass the mutation on to their children. Persons found by 
predictive testing to be susceptible or certain to develop a late-onset disorder may 
face even greater reproductive challenges than unaffected carriers, given that some 
are affected by autosomal dominant mutations. This mode of inheritance means that 
any child of theirs has a 50 per cent chance of inheriting the mutation (and therefore 
the disorder), regardless of with whom they procreate. Female carriers of X-linked 
genetic mutations have a similarly high risk of passing on the disorder to any male 
offspring and carrier status to female offspring. A couple who are both carriers of the 
same autosomal recessive mutation, on the other hand, will have a 50 per cent risk of 
passing on carrier status but only a 25 per cent risk of having a child with the disorder 
in question. Additionally, one has to have a life in order to have reproductive concerns. 
Predictive genetic tests often test for genetic mutations that threaten life itself. 
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While some parallels may be drawn between the effects of testing for carrier status as 
part of a screening programme and testing an at-risk individual on request, there is 
also need for great caution in comparing the two scenarios.230 Much of the research 
on the effects and efficacy of carrier screening programmes focuses on people who 
underwent such screening more than a decade ago. Genetic knowledge, clinical 
genetics practice and genetic counselling have evolved since that time. 
Even in respect of more recent research into the effects of carrier screening programmes, 
the correlation is tentative, at best. Participants in carrier screening programmes, and 
at-risk individuals who seek testing for themselves, may differ in terms of their baseline 
understanding and emotions, the information that they are given, the opportunity for 
questions, the availability of genetic counselling before, during and after testing and 
the handling of test results. There may also be additional pressure to participate in 
testing when it is part of a programme offered to all of one’s peers.231 
The Australian Law Reform Commission noted that ‘the information and counselling 
needs of screening program participants differ from those who have had experience 
of a disorder in their families’.232 Participants in screening programmes may have little 
understanding of the disorder for which they are being tested, because they may never 
have met an affected person or had the opportunity to learn about the condition. 
Added to this, ‘the large scale or “production line element” of population screening 
may place time constraints on obtaining consent and providing counselling’.233 
However, the fact that carrier screening programmes for certain disorders are 
seen as relatively common within schools in some communities is arguably an 
acknowledgement by those communities, at least, that carrier screening of minors 
is either not significantly harmful, or the potential benefits outweigh the potential 
harms.234 Additionally, the education sessions and requisite one-on-one meeting 
with a counsellor as part of the Australian high school carrier screening programmes 
appear to have resulted in significant knowledge gains and alleviation of anxiety for 
the participants in those programmes. And, the evidence from both the Montreal 
and more recent Australian Tay-Sachs disease screening programmes indicates that 
carrier screening at high school is beneficial to young people.235 
2.7  the dearth of evidence
There appears to be no evidence for some of the purported benefits and harms 
recorded in Tables 1 and 2. Indeed, there is evidence contradicting, or at the very 
least calling into question, some of the purported benefits and harms. 
While Duncan’s research, for example, revealed that minors did misunderstand 
aspects of the heritable disorder for which they were at risk when younger (often 
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when they first became aware of the disorder in a family member), she reported 
very few misunderstandings post counselling and testing. That is, none of the young 
people that she interviewed appeared to labour under misconceptions about what 
the test result meant for their futures. 
It has been argued that ‘testing during adolescence might interfere with the natural 
separation process that needs to occur between parents and their children’236 because 
of a bond between an affected minor and an affected parent, or because of guilt over 
not being affected when one’s parent is. A range of evidence exists relating to these 
issues (discussed in greater detail shortly) indicating that the outcome of genetic 
testing very much depends upon each individual family context. For example, one 
individual noted that she felt her relationship with her mother had eased somewhat, 
perhaps because her mother was not so worried anymore:
So	she	sort	of	let	me	go	off	and	do	what	I’ve	gotta	do,	you	know,	in	my	own	way,	
and	she	knows	that’s	the	sort	of	way	I’ve	got	to	do	my	thing,	like,	she	can	try	and	




The purported benefits and harms need to be critically challenged, and not simply 
accepted, until they are confirmed by evidence. 
Some of the purported benefits and harms listed are imported from other contexts, 
and some could also arise in other scenarios: they are not unique to the genetic 
testing context. For example, unease about interrupted school work and time out of 
school may certainly be a relevant concern for competent minors, particularly if they 
are at an important stage in their school careers. However, having to take time out of 
school is not unique to the genetic testing scenario – it is an unfortunate potential 
consequence of any kind of illness experienced during childhood. For older minors, 
concerns about work and work performance can also occur as a result of many other 
medical conditions, and they are also perhaps even more of a concern for adults.
Duncan points out that long-term follow-up of minors who have undergone genetic 
testing is particularly important, because there is evidence from the HD literature 
that the consequences and value of undergoing predictive testing can change as the 
time of onset approaches.238 
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2.  harms apply to adults also
Arguments against genetic testing of competent minors must be examined against 
the discourse around genetic testing of adults. As Duncan says
…	it	is	clear	that	not	all	of	the	arguments	used	to	oppose	predictive	genetic	testing	




Many of the purported and proved harms of genetic testing are just as, and often more, 
relevant to adults. However, some benefits and harms are more specific to competent 
minors because of their stage of life, e.g. most are in the process of considering career 
and other future options, rather than already having made these decisions, and most 
live in the family home. Certain harms, such as those arising from family relationships, 
may be exacerbated for young people who live in the family home with their parents 
and siblings, and who may be financially reliant on their parents. Harms relating to 
stigmatisation and feeling different may also impact in particular upon teenagers, 
for whom peer support and acceptance is very important.240 However, the benefits 
relating to the ability to make future plans using the test information may be more 
palpable for minors than adults, given that minors will have greater opportunity to 
use the information in a timely fashion. 
Many of the purported benefits241 of genetic testing of competent minors upon request 
may also accrue to adults, e.g. a reduction in risk behaviour, reduced uncertainty and 
contact with a knowledgeable health professional. However, the benefits of genetic 
testing for adults will not be discussed further because adults are not the focus of 
this section of the report, and there is a larger and more relevant body of evidence 
specifically related to the effects of genetic testing in adults. 
2.  general discussion of harms and benefits 
The harms and benefits of genetic testing of minors are now discussed without 
further differentiation between the types of genetic testing undertaken because, as 
discussed earlier in the context of purported harms and benefits, many of the same 
benefits and harms apply, to varying degrees, to all kinds of genetic testing (except 
perhaps symptomatic genetic testing, which more closely parallels general medical 
testing). 




By this stage, it will hopefully be clear to the reader which benefits and harms may 
apply more specifically to persons tested for carrier status and which may apply to 
those tested for a late-onset disorder. The added complexity of susceptibility testing 
has also been discussed. 
2.0  Family issues
Family issues are discussed first because the evidence relating to the effects of genetic 
testing on family relationships is varied and complex, and does not fit neatly into the 
dichotomy of benefits and harms. Family issues are complex in the context of genetic 
testing, not least because the genetic information revealed has implications for all 
family members. 
Family relationships and issues also potentially comprise a more salient aspect of 
the genetic testing process for competent minors for the reasons outlined earlier: 
competent minors generally live in the family home with their parents and siblings, 
and are reliant on their parents both financially and emotionally to some degree. 
How each minor will react to the vagaries within the family context as result of 
genetic testing is far from clear. There is great speculation about whether genetic 
testing strengthens or strains family relationships. There is limited and contestable 
evidence for both propositions. 
No evidence has been found by this author to suggest that a competent minor who 
requests a genetic test and is found to be mutation positive is likely to be scapegoated 
or treated poorly within the family because the mother or father are reminded of 
their own ‘unacceptable traits’.242 That of course is not to say that this would never 
occur, but evidence for the proposition is currently limited in this specific context. 
It has been suggested that an affected parent may not be able to provide appropriate 
support for a minor who tests positive for the genetic mutation, because of the parent’s 
own struggle with the condition. Evidence directly on point is also lacking for this 
proposition. Additionally, a lack of parental support for a minor facing current or 
future health issues can equally occur in other contexts, and is not unique to genetic 
testing. It is an issue that needs to be considered in pre-test genetic counselling, to 
enable the minor to identify and establish other support networks. We reiterate, 
however, that the evidence is uncertain. Indeed, there is evidence that returning a 
mutation-positive test result actually creates or strengthens bonds between affected 
parents and children.243 
Some minors who test mutation positive may especially suffer while watching a 
symptomatic parent struggle with the disorder, deteriorate or even die. The strength 
of this purported harm of predictive genetic testing is weakened by its applicability to 
adult children also. However, a minor who lives with a symptomatic parent would be 
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exposed to that parent on a more regular basis. On the flipside, it may help the minor 
to confront the reality of the situation, and even inspire strength. It may very much 
depend upon how the parent and the rest of the family responds to the disorder. This 
is another issue that needs to be thoroughly explored and prepared for in genetic 
counselling. Note that unaffected minors and indeed any minors with ill parents will 
also be affected by watching a symptomatic parent struggle with a condition.
There is evidence that minors are negatively affected by mutation-positive results 
in parents and siblings, regardless of their own test result. There is also evidence 
of slightly increased anxiety if a minor’s mother is positive for FAP and so is the 
minor; conversely, there is evidence of negative emotions such as guilt and worry for 
mutation-positive siblings when the minor is mutation negative.244 In the context 
of these pieces of research, the anxiety levels of control groups of at-risk minors 
not tested at all, or minors not at risk, might have been enlightening. One would 
expect some degree of anxiety among children with ill parents or siblings, regardless 
of whether or not they are themselves at risk for a similar or different condition. 
These results suggest that minors are likely to be troubled by family members’ 
conditions regardless of whether or not they are personally affected or have even been 
tested, or whether or not the affected family member is suffering from a heritable 
genetic illness or some other affliction. The possibility of negative feelings arising 
from test results of other family members is not a sufficient argument against genetic 
testing of minors upon request; it is something that must be managed. 
The impact of genetic testing upon family relationships is much more complex and 
contextualised than is suggested by propositions such as testing may ‘interfere with 
the natural separation process’, ‘drive a wedge or distance between family members’ 
or ‘force minors into the realization that their parents are not all-powerful’. Certainly 
minors’ feelings about genetic testing and test results seem to relate to their family 
relationships and other family members’ risk status in particular.
The young people that Duncan interviewed reported feeling concerned about their 
parents’ reactions to their test results. Some who tested mutation negative said that 
the happiness of their parents was the best thing about being tested, while others who 
tested mutation positive said that ‘seeing what it did to my parents’245 was the worst 
thing about being tested. 
There is also evidence that testing did result in negative family issues for some minors. 
One young woman found to be mutation negative for FAP, for example, perceived 
her affected mother to be jealous of her.246 Some young people who tested mutation 
positive admitted to feeling guilty or anxious that their siblings were affected.247 
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Yet many of the young people that Duncan interviewed reported that they had grown 
closer to family members, usually an affected parent, as a result of the testing process 
and the test result.248 
What is clear, from the limited evidence available about predictive genetic testing of 
minors, is that genetic testing is not undertaken in a vacuum: minors are aware of 
the impact of the genetic disorder, the testing process and the test results upon their 
family members (both present and future), and others around them. These issues 
must be explored during genetic counselling. 
There are as many unique family situations and relationships as there are families. 
For this reason, the potential benefits and harms for a particular competent minor 
seeking genetic testing can only be accurately assessed on an individual basis and 
generally against the backdrop of the family relationships. There may be further 
complexities where the minor does not tell the parents about seeking testing, or does 
not have their support for testing. Family counselling may be appropriate where all 
members are amenable. 
If these mixed reports tell us anything about how genetic testing can affect family 
relationships, it is that every individual and every family is unique and the minor’s 
family situation must be carefully explored in genetic counselling pre-testing.
2.  harms
Many of the harms that may arise in the context of genetic testing of competent 
minors, upon request, may also arise in the context of genetic testing of adults. 
Additionally, many of the harms are not exclusive to genetic testing situations, and 
others are not intrinsic and can be mitigated or managed.
2.11.1  Negative psychological effects
There is certainly evidence of negative psychological effects resulting from genetic 
testing, both in minors and adults. Indeed, it is arguable, based on the limited evidence 
available, that predictive genetic testing may be more harmful psychologically for 
adults than for minors, given Michie et al.’s findings in respect of minors and adults 
tested for the FAP mutation.249 Adults in most cases have lived with the knowledge of 
being at risk for a longer period, with all that entails. Being at risk for the condition 
may constitute a much greater part of the adults’ identity and life story; they will 
most likely have made more life choices based upon their at-risk status; and there 
is evidence that at risk people often live as if they were mutation positive. Finding 
out that one was mutation negative, after having made significant sacrifices, perhaps 
involving career, marital or reproductive choices, on the assumption that one was 
affected, could clearly be devastating. 
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Some negative feelings as a consequence of genetic testing are almost inevitable, 
particularly when one tests positive for a life-threatening disorder. The probability 
of feeling some negative psychological effects needs to be fully explored in genetic 
counselling before testing. Counselling needs to be available to follow up minors 
who receive mutation negative results also, because there is evidence that people 
experience negative psychological effects even after receiving a ‘good’ result.
The severity and duration of psychological harm caused by genetic testing may vary 
according to the type of testing, the penetrance of the condition tested for and the 
medical interventions available, if any. However, there is little evidence comparing 
the effects of genetic testing for one kind of disorder versus the effects of testing for 
another disorder. 
The one young person that Duncan interviewed who expressed regret at undergoing 
a predictive test had tested positive for the FAP mutation.250 Interestingly he said 
‘what you don’t know won’t hurt you’, when in actual fact there are medical benefits 
available for carriers of the FAP mutation. That same young man appeared to have 
been tested at the behest of his parents, rather than of his own volition: ‘Dad just 
organised it, and I just had to come in, get the um blood test’.251 
The likelihood of regret might be less of a concern when one is tested of one’s own 
volition. The possibility of regret can hopefully be minimised by full exploration of 
the possibilities and consequences before one decides whether or not to be tested. 
However, it may prove impossible to entirely eliminate the possibility of regret 
regarding the seeking of information that one does not want to hear. 
Undoubtedly negative psychological effects frequently occur for anyone who discovers 
that they have a debilitating or life-threatening disorder. Such feelings are not the 
exclusive domain of those who have undergone predictive testing for a disorder. 
2.11.2  Establishing an identity might be difficult
To date there appears to be no evidence that competent minors who seek genetic 
testing have difficulty establishing an identity if they test positive for the disorder. 
The suggestion that one might have difficulty establishing an identity seems to be 
more specifically related to minors than adults, given the period of growth and 
development young people go through. However, note the concern raised earlier 
that adults have lived at risk for longer and thus may be equally if not more likely 
to experience an identity crisis upon receiving their test result. The suggestion also 
appears to ignore the fact that the minor is already living as an at-risk individual in 
an affected family, and is not a tabula	rasa upon which the test results are laid.252
Genetic counselling can help both minors and adults incorporate their genetic status 
and test results into their identities.
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2.11.3  Perception that a mutation-positive minor is already ill
The concern that people, particularly parents, will treat an individual found mutation 
positive for a late-onset disorder as if they were already ill is a concern more frequently 
raised in the context of genetic testing of younger minors at their parents’ request. 
However, it is also a potential harm that could be faced by anyone who tests positive 
for a late-onset disorder, including adults. 
Again, the argument fails to consider the baseline harms of simply being at risk for 
a condition. Minors, and others, may already be treated as if they have the condition 
and are ‘ill’ if they are at risk, regardless of whether or not they undertake predictive 
testing. Indeed, it has been suggested that some family members may be singled out 
as being ‘affected’ within a family, without testing, perhaps because their health is 
generally more fragile, or they most closely physically resemble the affected parent.253 
Appropriate counselling before the decision is made to undergo testing, during the 
testing process and after testing should aim to curb this type of misunderstanding 
and misuse of information: the potential harm is an information management 
problem that can be addressed. 
2.11.4  Concerns about disclosure, integration and stigmatisation
Concerns about disclosure are also relevant to adults – they are not unique to young 
people. Where confidentiality requirements and rules are adhered to and correct 
processes are followed the disclosure of test results to others should not be an issue 
(except where disclosure is required by law). Minors who have given their own 
competent informed consent to genetic testing are also entitled to confidentiality: 
their results should not be disclosed to anyone else, including their parents, except 
where one or more lawful exceptions applies. This is discussed in more detail later, 
under the heading ‘Privacy’.
Competent minors may be particularly vulnerable to anxiety about integrating 
with their peers and being stigmatised if their test results are known, given the 
social pressure to conform and ‘fit in’ during adolescence.254 However, disclosure of 
information can and should be managed. Fear about inappropriate disclosure is not a 
reason to prohibit genetic testing of minors: it is an impetus to safeguard confidential 
information. The person tested should be in control of the information. Managing 
the information and deciding when to tell others, including potential sexual partners, 
is an issue that needs to be covered in genetic counselling of minors. 
2.11.5  Being too young to understand
The potential harm of being too young to understand the implications of the genetic 
test should never be an issue if the competency assessment of the minor requesting 
testing is appropriately managed. The focus of this section is on genetic testing of 
competent minors upon request.
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2.2  Benefits
2.12.1  Enhanced autonomy, competence and confidence
There is explicit evidence that undertaking genetic testing on the basis of the minors’ 
own authority enhances their confidence: ‘… it required my signature, not mum’s, I 
remember that which was of course quite surprising being under 18, it actually made 
[me feel] quite good and nice and important’.255
There is also evidence that decision-making more generally enhances minors’ 
competence: ‘research has long-since confirmed the common-sense belief that 
children need to exercise choice in order to acquire self-respect and a sense of 
responsibility’.256
2.12.2  Self-knowledge promotes more autonomous decision-making
A number of the young people whom Duncan interviewed indicated that they 
had readjusted their career and reproductive expectations because of the genetic 
information and self-knowledge gained. Indeed, the concept that self-knowledge 
promotes more autonomous decision-making is arguably an a	 priori proposition, 










Even if one accepts that increased self-knowledge enhances autonomy, one need not 
accept that predictive testing of minors always benefits their autonomy. The benefit 
of self-knowledge to the minor’s autonomy arguably only accrues when choice	can be 
exercised regarding whether or not to acquire more information, including genetic 
information. In this way, predictive testing of minors who cannot consent or who 
have not consented on their own behalf does not necessarily enhance their autonomy 
by giving them more self-knowledge upon which to make future decisions. And yet, 
self-knowledge is an added benefit of being able to exercise one’s own choice in 
respect of testing. 
2.12.3  The impact of genetic testing on minors’ behaviour
There is limited evidence as to how genetic testing affects minors’ behaviour. Thus far 
there appears to be little evidence that genetic testing of minors causes behavioural 
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problems, and yet there is quite a body of evidence (relative to the limited total 
amount of available evidence) to indicate that genetic testing can impact positively 
on problem behaviour. Personal accounts from the young people that Duncan 
interviewed indicate that some of them indulged in serious risk-taking before being 
tested, including drug abuse and criminal or disorderly behaviour. Some felt that 
having the genetic information influenced their risk-taking behaviour positively.258 
Codori’s research into the effects of testing for FAP also indicates that predictive 
testing was not associated with an increase in behavioural problems.259 The limited 
evidence suggests that genetic testing of minors, at their request, might impact more 
positively than negatively on their behaviour.
2.12.4  Testing relieves uncertainty
Relief of uncertainty is another effect of genetic testing, which is arguably knowable 
a	 priori (to the extent that a useful result is produced by the test). There is also 
evidence of the relief experienced by young people who have been tested, as outlined 
in Duncan’s research. However, the evidence is certainly limited (see the earlier 
discussion on Duncan’s research), and there has seemingly been no longer-term 
follow-up on the value of reduced uncertainty for minors versus the knowledge that 
one has or is predisposed to a potentially terminal condition.
2.12.5  Direct contact with a knowledgeable health professional
Direct contact with and counselling from a health professional with a good 
understanding of the clinical and ethical aspects of genetic testing can be of major 
benefit to a minor (and others). Up until contact with such a health professional the 
minor may have gained all information and ideas about the disorder from within the 
family, directly or indirectly. Contact with a knowledgeable health professional can be 
extremely beneficial in that context, regardless of whether or not testing goes ahead.
2.12.6  More accurate genetic counselling becomes possible 
More accurate genetic counselling is also a self-evident benefit (where the results of 
the test are not inconclusive). A minor attending genetic counselling to discuss and 
learn about the disorder and the implications of the disorder will enjoy more accurate 
counselling about the risk and the condition, no matter whether a mutation-positive 
or mutation-negative result is received. After testing the minor can be counselled 
as to the implications of the result. For example, counselling for those who receive 
a mutation-negative result may focus on the fact that it is normal to experience 
negative feelings after a ‘good’ result, and how to deal with family issues, including 
family members who are mutation positive. Counselling for those who test mutation 
positive, on the other hand, can assist them to adjust to the information, explore the 
implications and plan for the future.
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2.12.7  Undergoing testing at an age-appropriate time
There is some evidence that the young people that Duncan interviewed felt that the 
potentially negative or fearful features of going through predictive genetic testing 







However, to the extent that minors were not as worried because they did not 
understand the implications of the genetic test is not an argument in favour of testing 
competent minors upon request. This argument could be used to justify genetic 
testing of young children who cannot consent on their own behalf, which is dealt 
with elsewhere in this report. 
However, as highlighted earlier, Michie et al. found more negative effects in terms of 
increased anxiety levels associated with pre-symptomatic testing for the FAP mutation 
amongst adults than amongst minors. Suggestions that the difference in anxiety 
levels between children and adults were due to the minors’ lack of understanding 
regarding the test results or their implications were not supported by the data (see 
earlier discussion).262
2.12.8  Time and opportunity to plan future; time for adjustment and research 
One of the major arguments in favour of testing competent minors upon request 
(and related to the earlier point) is that testing at such a time gives the minor greater 
opportunity and time to plan for the future around the information revealed. For 
many minors, choosing subjects to study towards a career begins in high school. 
The benefit of having time for adjustment and research is also related to the earlier 
points. One woman recalled being caught ‘off-guard’ by her own breast cancer diagnosis 
and having felt rushed into making uninformed decisions. She considered that a 
positive genetic test result would have allowed her time for research and adjustment 
and in turn more informed decision-making. ‘Time to make good decisions and to get 
information gathered. … when I got my diagnosis, I didn’t feel like I had the time … I 
didn’t take time to do the research because I wasn’t emotionally ready to do that.’263
A young woman who knew she had a BRCA 1 mutation would have more time to 
digest the information. She might ‘decide against a long university education to have 
children early and pursue a university career after having had bilateral mastectomy’,264 
rather than being taken by surprise and rushing into a mastectomy. 
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2.12.9  Friendship issues
How the test result will affect their friendships and other peer relationships might be 
something that minors are particularly concerned about. In terms of the reactions of 
friends to the genetic testing process, there is less available evidence than there is for 
family reactions. However, the little evidence that exists (from the comments made 
to Duncan) suggests that, like family relationships and reactions, whether testing 
will impact negatively or positively on friendships appears to depend upon the 
individual’s circumstances and friends. At least two young people, for example, told 
Duncan that friendships had flourished as a result of the genetic testing process,265 
while others indicated that they had been let down by people, or did not get as much 
support as they needed.266
Minors should be able to control their genetic information and thus restrict their 
friends’ knowledge of their genetic status if they wish. Special genetic counselling 
around how to deal with friends’ and peers’ questions and reactions may be 
particularly important for minors, if this is likely to be an issue. 
2.12.10  Positive psychological effects of receiving a mutation-negative result
Duncan reports numerous positive psychological effects, as a result of mutation-
negative results, from her interviews with minors who had been through the testing 
process. The relief, joy and excitement are palpable from their comments.
2.12.11  No longer being treated as if one has the disorder
The concern that people who are at risk for a heritable disorder may be treated by 
family members or others as if they already have the disorder is discussed earlier. 
Returning a mutation-negative result would hopefully quell this kind of behaviour. 
However, cessation of this kind of treatment should not need to be considered as a 
‘benefit’ of a mutation-negative genetic test result. A person known (by whatever 
means) to be at risk for a heritable disorder should not be treated as affected until 
that person confirms the information (and obviously, at that point, there are also 
anti-discrimination protections.) This is a concern relevant to adults too (perhaps 
even more so) and it involves much wider privacy and discrimination issues than can 
be adequately addressed here.
 
2.  magnitude of benefits and harms
The probability of occurrence of any of the benefits and harms discussed, and 
their magnitude, will depend upon the individual and support networks. As stated 
earlier, in the discussion about predictors of reactions to predictive HD testing, 
individuals’ negative feelings prior to testing (e.g. avoidance of HD-related situations 
and dissatisfaction) were often exacerbated post testing (e.g. avoidance behaviour, 
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depression, suicidal ideation).267 The magnitude of benefits and harms may further 
depend on the test result; the medical interventions available, if any; the probability 
of developing the disorder; and the likely age of onset of the disorder. 
 
2.  the impact of the test result
Many of the purported non-medical benefits and some of the purported harms 
may accrue regardless of whether the genetic test results are positive for the genetic 
mutation, or mutation negative. It is not only those who receive a mutation-negative 
result who might suffer some harm. Certainly there is evidence of non-medical 
benefits accruing to minors who receive a mutation-positive result, as well as to those 
who receive a mutation-negative result. Thus, anxious desire for a mutation-negative 
result is not the only reason for seeking a genetic test, and a mutation-negative result 
is not the only outcome that may produce benefits. 
However, the possibility of a minor returning a mutation-negative result commonly 
appears to be overlooked in much of the literature, which seems to focus on the 
worst-case scenario.268 
2.  the importance of an individual baseline assessment before genetic testing  
 and the harms of not testing
Duncan criticises commentary on genetic testing of minors which appears to assume 
that a minor, or any individual, comes to testing as a blank slate, i.e. an empty page 
upon which the results can be imposed and which can be utilised to predict the 
effects of testing.269
For example, simply accepting at face value that interrupted school time and school work 
may be harmful by-products of genetic testing denies recognition that at-risk minors 
may be having difficulties at school and in other areas of their lives anyway, including 
difficulty concentrating or a tendency to act up. Duncan’s interviews with young people 
revealed that a number of them were engaging in risk behaviours pre-testing.270 
An implicit assumption that minors are blank slates pre-test may be seen in the 
suggestion that there is no harm in testing being delayed until the minor reaches 
the legal age of majority or the commonly and arbitrarily mooted age of eighteen. 
Duncan’s interviews with minors who had lived with the knowledge of their at-risk 
status for years before being tested suggest that there may be harm in making a minor 
wait until the age of eighteen to be tested. The reasons why the minor is seeking the 
test may be particularly insightful in this regard. 
The evidence outlined earlier, particularly from Duncan’s study, reveals that many 
minors (and adults) convince themselves that they are mutation positive before or 
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without being tested, seemingly to prepare themselves for the worst. Thus, some of 
the harms of genetic testing may already apply to minors who are living as if they are 
mutation positive. For example, they may be making career, relationship or other 
decisions or sacrifices based upon a false idea of their future health.
Not all commentators suggest that people are blank slates pre-testing. Fanos is one 
commentator who suggests that, rather than being a blank slate, minors who have 
grown up in families with affected persons may be more affected by genetic testing 
because ‘the impact of a testing procedure will be overlaid upon the pre-existing 
stresses and adaptations of the child who may be at risk for the genetic disorder’.271
A better approach might be to consider the minor and the situation as unique, and 
assess the likely effects of testing without making assumptions that the minor is a 
blank slate entirely unaffected by being at-risk, or is more or less prepared for testing 
than others, who are not significantly at risk, might be. 





autonomy	 [Fletcher	 et	 al.,	 1985],	 but	 rather	 upon	 preconceived	 assumptions	
and	values	that	may	prove	invalid	on	a	case	by	case	basis?	…	Has	the	geneticist	
effectively	 imposed	 upon	 others	 his/her	 own	 values	 and	 beliefs	 about	 what	 is	
‘best’	for	the	child	and	the	family	[Shaw,	1987]?272
2.  conclusion
Empirical evidence of benefits and harms of genetic testing is very limited. However, 
the most recent and extensive evidence points towards testing having the potential to 
be more beneficial than harmful for competent minors who request testing.
For some of the purported benefits and harms there is no evidence, or inadequate 
evidence only. Other purported harms do not sufficiently justify a conclusion against 
genetic testing of competent minors upon request because they relate equally to other 
health-care contexts; they relate to adults also; or they can be mitigated or resolved 
via alternative methods as opposed to blanket prohibition. 
Many of the potential harms should not be an issue if correct processes are adhered 
to, particularly around clear procedures and timeframes for counselling and testing; 
and clear rules and procedures regarding method, timing and persons to whom 
disclosure of results will be made. 
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Some of the benefits of genetic testing are knowable a	priori and, at the time of writing, 
there appears to be more convincing evidence for the benefits that arise from genetic 
testing than for the harms, particularly for competent minors. Evidence of harms is 
limited and harms specifically related to competent minors are even more speculative. 
Additionally, some of the harms projected as a result of genetic testing can already be 
seen in the context of minors living at risk for a heritable genetic mutation. 
There is a great need for thorough genetic counselling before a decision is made about 
whether to undergo genetic testing. The benefits and harms of testing frequently 
depend on the individual’s life story and relationships prior to testing, and plans and 
level of support after testing (particularly where other harms relating to information 
management have been dealt with appropriately). Evidence from predictive testing 
for HD in adults shows that predictors of negative psychological effects post testing 
included negative feelings in the pre-test period.273 





Given the absence of convincing evidence that genetic testing is too harmful for 
minors generally, competent minors should not be denied the opportunity to undergo 
genetic testing at their request. The next section will address whether the law currently 
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.  Purported benefits and harms
The few genetic cancer predisposition syndromes for which genetic test results can 
alter clinical management in children include: FAP; multiple endocrine neoplasia, 
types 1 and 2 (consisting of autosomal dominant mutations in genes regulating cell 
growth, characterised by tumours in the endocrine glands); Von Hippel-Lindau 
(autosomal, dominantly inherited multisystem disorder characterised by abnormal 
growth of blood vessels);277 retinoblastoma (childhood cancer arising from immature 
retinal cells in one or both eyes);278 and neurofibromatosis, type 2 (characterised by 
multiple tumours on the cranial and spinal nerves).279,280 
What about the non-medical benefits regarding genetic testing of children? 
Interpretations of best interests or benefit are integral to any debate around genetic 
testing of children. For example, some may argue that carrier testing or predictive 
genetic testing, even for an untreatable disorder, is in a child’s best interests because:
• It alleviates anxiety for both child and parent: a less anxious parent makes for 
a less anxious child. If the results are negative then much of the anxiety can fall 
away immediately and, even if the results indicate the genetic mutation being 
tested for is present, the certainty may alleviate some anxiety.
• It facilitates open relationships within the family and relevant community.
• It might reveal that the child is mutation negative.
• It gives a child time to adjust to the prospect of life with the condition.
• It allows the parents to secure the best environment that they can for the child, 
e.g. a house with suitable access that is near a hospital and appropriate school.281
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Opponents of genetic testing of children argue that carrier testing and predictive 
genetic testing are not in a child’s best interests, for a variety of reasons:
• Development of a perception that the child is ‘ill’ with attendant negative 
parental (and other) attitudes towards the child.
• Strict health (including dietary and environmental) regimes and treatments 
may be implemented with few if any proven benefits. 
• Low self-esteem on the part of the child.
• Serious psychological maladjustment, perhaps leading to depression and even 
suicide.
• Parental guilt, impacting negatively on the child.
• Social discrimination, e.g. in employment and access to insurance.
• Violation of the child’s future autonomy and ‘right not to know’.282 
These benefits and harms are similar to those postulated by the professional position 
statements and guidelines discussed earlier, and reinforce the comments made by 
various groups which were surveyed regarding their attitudes towards genetic testing 
of children. Unsurprisingly, they are also similar to the putative benefits and harms 
of genetic testing of competent minors. 
Much of the discussion in those documents and in the preceding section on 
competent minors therefore also applies to requests for carrier or predictive testing 
of children who cannot give their own consent. This section focuses specifically on 
the different issues raised by genetic testing of children who cannot give informed 
consent (compared to testing of those who can). 
Generally, the harms mentioned in respect of genetic testing of incompetent minors 
are variations on the same themes: violation of the minor’s right to autonomous 
decision-making; and potential psychosocial harms as a result of testing in childhood. 
Arguments centre around the lack of choice for the minor, and violation of the right 
to ‘not know’ genetic status, the lack of confidentiality afforded to minors who 
undergo genetic testing in childhood and the psychosocial harms that may eventuate 
within the family and wider social context as a result of testing. 
That parental requests may dictate the services made available seems potentially 
of concern since parents may not always act in the interests of the specific child; 
rather, they may have their own interests, or the interests of other family members, 
in mind. 
Some commentators argue that parents have a right to consent to genetic testing of their 
children because they know their children best and they bear primary responsibility 
for them.283 Others argue that parents need to exercise significant discretion in raising 
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their children, and that society has an interest in protecting the family as the primary 
child-rearing institution.284 Allowing health professionals to regulate parents’ access 
to medical procedures for their children is therefore paternalistic. 
To draw out the issues, Wright Clayton hypothesises about the potential sequelae to 
predictive testing of a child for a later onset condition (in this case, breast cancer):
Hopefully,	the	parents	would	help	their	children	to	prepare	for	the	surveillance	






if	 not	 misguided	 for	 any	 number	 of	 reasons.	 First,	 inherent	 in	 the	 nature	 of	




.2  lack of evidence 
Although there is more evidence on the effects of predictive or carrier testing in adults, 
children are not small adults: they have their own set of interests, vulnerabilities, 
capacities and needs.286 There is a dearth of evidence regarding the effects of predictive 
testing of children for early or late-onset conditions. The limited evidence that exists 
indicates that there may be some benefits – or a lack of significant harm – as a result 
of testing. However, long-term studies may be needed to reach a valid conclusion on 
the balance between benefit and harm.  
Research into predictive testing of minors for the FAP mutation comprises the largest 
body of evidence relating to the effects of predictive testing of minors.287 Most of the 
children tested for FAP (involved in the research presented earlier) were tested on 
the basis of parental consent, rather than their own. Codori et al. surveyed children 
aged six to sixteen in their first study, and children aged five to seventeen in the later 
study. Parents gave informed consent for their children to participate in the study, 
and children assented.288 Michie et al. studied minors aged ten to sixteen, who were 
tested upon parental consent.289 
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Comments from many of the young people tested for FAP and interviewed by 










The evidence from the three studies outlined earlier in relation to predictive testing of 
minors for the FAP mutation,291 and from Duncan’s research, appears encouraging, in 
that no major harms were associated with testing, even when minors tested mutation 
positive.  Any reported negative psychological effects were mostly subclinical and 
were associated largely with minors who had affected mothers or siblings.   
Minors who received a positive test result during Michie et al.’s study displayed 
anxiety and distress levels within the normal range, while 43 per cent of affected 
adults displayed clinically significant anxiety levels. 
The limited evidence available supports the appropriateness of such testing. However, 
these findings may be limited to testing for conditions for which there are beneficial 
medical interventions available. The availability of medical interventions may have 
helped the minors cope with the information that they had tested mutation positive.   
In terms of benefits recorded as a result of predictive testing for HD in young people 
(e.g. those young people tested for HD by Duncan), even greater caution is required if 
inferring that similar benefits may accrue to children tested for untreatable disorders 
on the basis of parental consent, rather than their own. Much of the emphasis in the 
discussion on competent minors focuses on the benefits of predictive genetic testing 
that may accrue explicitly as a result of testing being undertaken pursuant to the 
minor’s own autonomous choice. 
Additionally, predictors of outcomes identified by the literature on predictive testing 
for HD in adults cannot be similarly applied with respect to minors who cannot 
give their own informed consent to genetic testing. For younger children it will not 
be possible to evaluate ego strength, depression levels and coping strategies pre-
testing, making it even more difficult to predict the effects of testing on them than on 
competent minors or adults. 
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There is a lack of evidence of benefits of childhood genetic testing for untreatable 
late-onset disorders; there is also a lack of evidence of harm caused by such testing. 
However, there are two other major arguments opposing genetic testing in children 
where it is not medically indicated: testing upon the basis of parental consent violates 
the minor’s autonomy and right not to know the information; and such testing results 
in a potentially detrimental breach of confidentiality regarding the minor’s genetic 
information.
.  violation of autonomy
It is argued that carrier or predictive genetic testing in childhood breaches a child’s 
future autonomy by removing the right to make a decision about testing as an 
autonomous adult or competent minor. Such testing precludes the possibility that, 
as an adult, the individual might have preferred to live with uncertainty instead of 
certain knowledge of the mutation.292
However, it has been argued in response that parents make many decisions to try and 
‘shape their children’s futures in ways that both broaden and narrow the children’s 
options’. Many states (including our own) grant parents much authority and leeway 
in terms of how they raise their children, and only intervene when there is evidence 
a child might be significantly harmed by a parental decision or action (or omission). 
There is as yet insufficient evidence that predictive testing for late-onset conditions 
harms children or adolescents so as to warrant state intervention.293 Equally, however, 
there is insufficient evidence of benefit, so that – except in cases where benefit can 
derive from the test – there seems no reason to permit parents to consent on their 
child’s behalf.
Robertson and Savulescu have intimated that the claim that predictive testing 
infringes a child’s future autonomy rests upon the assumption that autonomy or 
liberty equates with having as many options open as possible. They argue, however, 
that more choice is not necessarily better; and that childhood testing does not result 
in reduced	options, just different options (e.g. growing up with information about the 
future). They also argue that genetic knowledge may in fact promote autonomy by 
enhancing the subject’s concept of self and self-knowledge, which in turn is useful for 
forming one’s own conception of the good life for oneself..294 
However, it is often cited that just 10–15 per cent of adults at risk for Huntington 
disease opt for testing to discover whether they have the genetic mutation,295 
indicating that, for some untreatable disorders at least, most adults exercise their 
autonomous choice in favour of not knowing. On this evidence is it fair to make that 
kind of decision for a child, when it is possible to delay such a decision indefinitely or 
permanently, and at least until adulthood?296 
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A major reason for emphasising a child’s right to autonomy or future autonomy 
in the genetic testing context is the concern to preserve the ‘right not to know’ 
whether one carries a genetic mutation, and all of the accompanying sequelae. 
Hogben and Boddington contend that arguments relying on the principle of respect 
for autonomy are often considered to be more important in relation to predictive 
testing. In contrast, knowledge of carrier status is often presented as if it is something 
to be used or not: as pragmatic information, primarily important for possible action 
rather than as significant knowledge per	se. This point has particular salience in the 
debate regarding genetic testing of younger children: 
In	 relation	 to	 predictive	 testing,	 implicitly	 autonomy	 is	 seen	 as	 control	 over	
self-image	or	self-knowledge,	which	is	ipso	facto	spoiled	by	revelation	of	disease	





The concern is that these assumptions tend to ‘ground conclusions regarding 
predictive testing in the relatively absolute notion of autonomy, and conclusions 
about carrier testing on the more contextualized notions of harm and benefit’.298 
.  Privacy and confidentiality
The protection of a minor’s autonomy when decision-making about genetic testing 
is connected with protection of privacy. A child who undergoes a genetic test in 
response to a parental request will generally not be granted the same confidentiality 
as an adult, given that the results will be disclosed to the parents, who are not bound 
by any legally recognisable duty to keep the information private. This issue and its 
implications are discussed in greater detail in the section on ‘Disclosure, confidentiality 
and privacy’.	Minors who undergo genetic testing as children cannot deal with their 
genetic information as they see fit or keep it private should they wish to do so. 
.  Predictive testing for untreatable early onset conditions
Predictive genetic testing for an early onset condition for which no beneficial medical 
interventions exist raises fewer concerns than testing for a similar late-onset condition. 
The same potential benefits exist, but not the same harms. The danger to the minor’s 
future autonomy to make the decision and potentially to exercise the right not to 
know the information is not as salient, as the child may never reach an age at which 
to decide whether or not to undergo predictive testing for the disorder in question 
– having already developed it, or having passed the likely age of onset unaffected. 
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Thus, the putative benefits of such testing (such as relieving anxiety, preparing for 
onset) may be weighted more heavily in this context regardless of whether or not the 
disorder is treatable. 
However, given that there are no clinical benefits to such testing, and there may be 
some harms (such as changed parental expectations and treatment of the child), 
parental requests for such testing should still be treated very cautiously. 
In terms of genetic testing providing some certainty, or alleviating anxiety, there is a 
great deal of residual uncertainty regarding the interpretation of predictive genetic test 
results. When genetic mutations are not fully penetrant, and only indicate susceptibility 
to a disorder, the risk of developing the associated disorder may vary according to a 
number of factors e.g. the particular gene(s) or genetic variation(s) in question; the 
total genetic environment;299 and environmental factors. Other factors that might 
affect a person’s likelihood of developing a particular disorder remain unknown.
Even if a genetic mutation is predictive or fully penetrant, the genetic test results cannot 
always, at least at this stage, predict the mildness or severity of the expression of the 
disorder in the particular person tested. Additionally, there are no guarantees as to the 
age of onset, or indeed if onset will occur at all, for any of these types of conditions. 
.  Discussion and conclusion
The same limited body of evidence exists against which to judge the effects of genetic 
testing both of minors who can give their own consent, and those who cannot. 
However, two very different conclusions have been reached, because of the different 
consequences of testing each group.
Testing on a competent minor’s request may be beneficial and may even enhance 
that minor’s competence and autonomy. However, when testing of a child who 
cannot give informed consent is not clinically indicated, there is reason to suspect 
that psychological or social harms may arise. These harms could arise from early 
knowledge that one will inherit an untreatable disorder; because one has had no 
say in whether or not to be tested; because parents may treat their child differently 
to the detriment of the child; or because of a lack of ability to prevent parental 
dissemination of one’s genetic information. Genetic testing for non-medical reasons, 
as a rule, should not be performed on minors who cannot give their own informed 
consent to testing because of the lack of evidence of the effects of genetic testing of 
minors; the fact that many adults choose not to discover their own genetic risk status; 
and the threats to a child’s autonomy and confidentiality. Where there are no medical 
benefits to genetic testing, such testing should be delayed until the minor can give 
consent to the testing. 
2
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